Loading...

Tashkin Donald

TitleDirector
InstitutionUniversity of California Los Angeles
DepartmentPulmonary Function Laboratories
Address32-176 CHS
Campus - 169017
Phone(310) 825-3163
vCardDownload vCard
    Other Positions
    TitleProfessor

    TitleCo-Director

    TitleCo-Director


    Collapse Research 
    Collapse Research Activities and Funding
    SPIROMICS Clinical Center
    NIH/NHLBI 268200900015C-4-0-1Feb 2, 2009 - Dec 31, 2015
    Role: Principal Investigator
    SPIRIOMICS Clinical Center
    NIH/NHLBI 268200900015C-4-0-2Feb 2, 2009 - Dec 31, 2015
    Role: Principal Investigator
    SPIROMICS Clinical Center
    NIH/NHLBI 268200900015C-1-0-1Feb 1, 2009 - Jan 31, 2016
    Role: Principal Investigator
    MOCSLID-CCC
    NIH/NHLBI R01HL089758Sep 18, 2008 - Jul 31, 2014
    Role: Principal Investigator
    Distal Lung Inflammation Effect on Asthma Exacerbations
    NIH/NHLBI R01HL080343Sep 15, 2005 - Jul 31, 2010
    Role: Principal Investigator
    Scleroderma Lung Study
    NIH/NHLBI U01HL060587Aug 10, 1999 - Jun 30, 2006
    Role: Principal Investigator
    PATHOPHYSIOLOGIC CONSEQUENCES OF SMOKED SUBSTANCE ABUSE
    NIH/NIDA R13DA012627Apr 15, 1999 - Mar 31, 2000
    Role: Principal Investigator
    LUNG HEALTH STUDY--LONG TERM FOLLOW UP
    NIH/NHLBI U10HL059293Feb 1, 1998 - Jan 31, 2003
    Role: Principal Investigator
    CLINICAL TRIAL OF INHALED STEROIDS IN COPD
    NIH/NHLBI U01HL050270Sep 4, 1993 - Dec 31, 1999
    Role: Principal Investigator
    Cocaine Smoking Effects on Lung Immunity &Host Defense
    NIH/NIDA R01DA008254Jun 1, 1993 - Aug 31, 2007
    Role: Co-Principal Investigator
    EARLY INTERVENTION/CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    NIH/NHLBI N01HR046022Sep 30, 1984 - Sep 30, 1999
    Role: Principal Investigator
    Pulmonary and Immunologic Effects of Marijuana Use on HIV and Viral Immunity
    NIH/NIDA R01DA003018Jul 1, 1982 - Apr 30, 2012
    Role: Co-Principal Investigator
    PULMONARY EFFECTS OF HABITUAL USE OF MARIJUANA
    NIH/NIDA R37DA003018Jul 1, 1982 - Sep 29, 2006
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Tashkin D. Marijuana and Lung Disease. Chest. 2018 May 17. PMID: 29778658.
      View in: PubMed
    2. Namas R, Tashkin D, Furst DE, Wilhalme H, Tseng CH, Roth MD, Kafaja S, Volkmann E, Clements PJ, Khanna D. Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo-Controlled Trials. Arthritis Care Res (Hoboken). 2018 Mar; 70(3):439-444. PMID: 28544580.
      View in: PubMed
    3. Morris MA, Jacobson SR, Kinney GL, Tashkin D, Woodruff PG, Hoffman EA, Kanner RE, Cooper CB, Drummond MB, Barr RG, Oelsner EC, Make BJ, Han MK, Hansel NN, O'Neal WK, Bowler RP. Marijuana Use Associations with Pulmonary Symptoms and Function in Tobacco Smokers Enrolled in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS). Chronic Obstr Pulm Dis. 2018 Jan 24; 5(1):46-56. PMID: 29629404.
      View in: PubMed
    4. Tashkin D, Wechsler ME. Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2018; 13:335-349. PMID: 29403271.
      View in: PubMed
    5. Kiertscher SM, Gangalum PR, Ibrahim G, Tashkin D, Roth MD. A Prospective Study of Humoral and Cellular Immune Responses to Hepatitis B Vaccination in Habitual Marijuana Smokers. J Neuroimmune Pharmacol. 2018 Jun; 13(2):219-229. PMID: 29340893.
      View in: PubMed
    6. Bhatt SP, Kim YI, Harrington KF, Hokanson JE, Lutz SM, Cho MH, DeMeo DL, Wells JM, Make BJ, Rennard SI, Washko GR, Foreman MG, Tashkin D, Wise RA, Dransfield MT, Bailey WC. Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years. Thorax. 2018 May; 73(5):414-421. PMID: 29326298.
      View in: PubMed
    7. Polosa R, Cibella F, Caponnetto P, Maglia M, Prosperini U, Russo C, Tashkin D. Health impact of E-cigarettes: a prospective 3.5-year study of regular daily users who have never smoked. Sci Rep. 2017 Nov 17; 7(1):13825. PMID: 29150612.
      View in: PubMed
    8. Kafaja S, Clements PJ, Wilhalme H, Tseng CH, Furst DE, Kim GH, Goldin J, Volkmann ER, Roth MD, Tashkin D, Khanna D. Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II). Am J Respir Crit Care Med. 2017 Nov 03. PMID: 29099620.
      View in: PubMed
    9. Anderson WH, Ha JW, Couper DJ, O'Neal WK, Barr RG, Bleecker ER, Carretta EE, Cooper CB, Doerschuk CM, Drummond MB, Han MK, Hansel NN, Kim V, Kleerup EC, Martinez FJ, Rennard SI, Tashkin D, Woodruff PG, Paine R, Curtis JL, Kanner RE. Variability in objective and subjective measures affects baseline values in studies of patients with COPD. PLoS One. 2017; 12(9):e0184606. PMID: 28934249.
      View in: PubMed
    10. Ferguson GT, Tashkin D, Skärby T, Jorup C, Sandin K, Greenwood M, Pemberton K, Trudo F. Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study. Respir Med. 2017 Nov; 132:31-41. PMID: 29229103.
      View in: PubMed
    11. Khanna D, Seibold J, Goldin J, Tashkin D, Furst DE, Wells A. Interstitial lung disease points to consider for clinical trials in systemic sclerosis. Rheumatology (Oxford). 2017 09 01; 56(suppl_5):v27-v32. PMID: 28992174.
      View in: PubMed
    12. Tashkin D, Taube C. Triple Therapy for Chronic Obstructive Pulmonary Disease Management. Are Our Expectations Fulfilled? Am J Respir Crit Care Med. 2017 08 15; 196(4):402-404. PMID: 28809512.
      View in: PubMed
    13. Tashkin D, Martinez FJ, Rodriguez-Roisin R, Fogarty C, Gotfried M, Denenberg M, Gottschlich G, Donohue JF, Orevillo C, Darken P, St Rose E, Strom S, Fischer T, Golden M, Reisner C. Corrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD" [Respir. Med. 120 November 2016 16-24]. Respir Med. 2017 08; 129:164. PMID: 28732826.
      View in: PubMed
    14. Han MK, Quibrera PM, Carretta EE, Barr RG, Bleecker ER, Bowler RP, Cooper CB, Comellas A, Couper DJ, Curtis JL, Criner G, Dransfield MT, Hansel NN, Hoffman EA, Kanner RE, Krishnan JA, Martinez CH, Pirozzi CB, O'Neal WK, Rennard S, Tashkin D, Wedzicha JA, Woodruff P, Paine R, Martinez FJ. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017 08; 5(8):619-626. PMID: 28668356.
      View in: PubMed
    15. Volkmann ER, Tashkin D, Li N, Roth MD, Khanna D, Hoffmann-Vold AM, Kim G, Goldin J, Clements PJ, Furst DE, Elashoff RM. Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II. Arthritis Rheumatol. 2017 07; 69(7):1451-1460. PMID: 28376288.
      View in: PubMed
    16. Martinez CH, Murray S, Barr RG, Bleecker E, Bowler RP, Christenson SA, Comellas AP, Cooper CB, Couper D, Criner GJ, Curtis JL, Dransfield MT, Hansel NN, Hoffman EA, Kanner RE, Kleerup E, Krishnan JA, Lazarus SC, Leidy NK, O'Neal W, Martinez FJ, Paine R, Rennard SI, Tashkin D, Woodruff PG, Han MK. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort. Ann Am Thorac Soc. 2017 May; 14(5):636-642. PMID: 28459622.
      View in: PubMed
    17. Halpin DMG, Decramer M, Celli BR, Mueller A, Metzdorf N, Tashkin D. Effect of a single exacerbation on decline in lung function in COPD. Respir Med. 2017 07; 128:85-91. PMID: 28610675.
      View in: PubMed
    18. Li X, Obeidat M, Zhou G, Leung JM, Tashkin D, Wise R, Connett J, Joubert P, Bossé Y, van den Berge M, Brandsma CA, Nickle DC, Hao K, Paré PD, Sin DD. Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease. EBioMedicine. 2017 May; 19:139-145. PMID: 28461224.
      View in: PubMed
    19. Hanania NA, Tashkin D, Kerwin EM, Donohue JF, Denenberg M, O'Donnell DE, Quinn D, Siddiqui S, Orevillo C, Maes A, Reisner C. Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease. Respir Med. 2017 05; 126:105-115. PMID: 28427541.
      View in: PubMed
    20. Desai M, Oppenheimer J, Tashkin D. Asthma-chronic obstructive pulmonary disease overlap syndrome: What we know and what we need to find out. Ann Allergy Asthma Immunol. 2017 Mar; 118(3):241-245. PMID: 28284529.
      View in: PubMed
    21. Meyers TJ, Chang SC, Chang PY, Morgenstern H, Tashkin D, Rao JY, Cozen W, Mack TM, Zhang ZF. Case-control study of cumulative cigarette tar exposure and lung and upper aerodigestive tract cancers. Int J Cancer. 2017 05 01; 140(9):2040-2050. PMID: 28164274.
      View in: PubMed
    22. Volkmann ER, Tashkin D, Roth MD, Clements PJ, Khanna D, Furst DE, Mayes M, Charles J, Tseng CH, Elashoff RM, Assassi S. Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease. Arthritis Res Ther. 2016 Dec 30; 18(1):305. PMID: 28038680.
      View in: PubMed
    23. Tashkin D, Volkmann ER, Tseng CH, Roth MD, Khanna D, Furst DE, Clements PJ, Theodore A, Kafaja S, Kim GH, Goldin J, Ariolla E, Elashoff RM. Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II. Chest. 2017 Apr; 151(4):813-820. PMID: 28012804.
      View in: PubMed
    24. Tashkin D, Kim HJ, Zeidler M, Kleerup E, Goldin J. Evaluating small-airways disease in asthmatic patients: The utility of quantitative computed tomography. J Allergy Clin Immunol. 2017 Jan; 139(1):49-51.e2. PMID: 27884601.
      View in: PubMed
    25. Wise RA, Acevedo RA, Anzueto AR, Hanania NA, Martinez FJ, Ohar JA, Tashkin D. Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus. Chronic Obstr Pulm Dis. 2016 Nov 15; 4(1):7-20. PMID: 28848907.
      View in: PubMed
    26. Volkmann ER, Tashkin D. Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies. Ann Am Thorac Soc. 2016 Nov; 13(11):2045-2056. PMID: 27560196.
      View in: PubMed
    27. Miles FL, Chang SC, Morgenstern H, Tashkin D, Rao JY, Cozen W, Mack T, Lu QY, Zhang ZF. Erratum to: Association of sugary beverages with survival among patients with cancers of the upper aerodigestive tract. Cancer Causes Control. 2016 Nov; 27(11):1301. PMID: 27757776.
      View in: PubMed
    28. Tashkin D. A review of nebulized drug delivery in COPD. Int J Chron Obstruct Pulmon Dis. 2016; 11:2585-2596. PMID: 27799757.
      View in: PubMed
    29. Tashkin D, Bateman ED, Jones P, Zubek VB, Metzdorf N, Liu D, Leonard T, Clerisme-Beaty E, Wise RA. Consistent improvement in health-related quality of life with tiotropium in patients with chronic obstructive pulmonary disease: Novel and conventional responder analyses. Respir Med. 2016 11; 120:91-100. PMID: 27817821.
      View in: PubMed
    30. Tashkin D, Martinez FJ, Rodriguez-Roisin R, Fogarty C, Gotfried M, Denenberg M, Gottschlich G, Donohue JF, Orevillo C, Darken P, St Rose E, Strom S, Fischer T, Golden M, Reisner C. A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD. Respir Med. 2016 11; 120:16-24. PMID: 27817811.
      View in: PubMed
    31. Miles FL, Chang SC, Morgenstern H, Tashkin D, Rao JY, Cozen W, Mack T, Lu QY, Zhang ZF. Association of sugary beverages with survival among patients with cancers of the upper aerodigestive tract. Cancer Causes Control. 2016 11; 27(11):1293-1300. PMID: 27539643.
      View in: PubMed
    32. Zafari Z, Sin DD, Postma DS, Löfdahl CG, Vonk J, Bryan S, Lam S, Tammemagi CM, Khakban R, Man SF, Tashkin D, Wise RA, Connett JE, McManus B, Ng R, Hollander Z, Sadatsafavi M. Individualized prediction of lung-function decline in chronic obstructive pulmonary disease. CMAJ. 2016 Oct 04; 188(14):1004-1011. PMID: 27486205.
      View in: PubMed
    33. Tashkin D, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016 09; 4(9):708-719. PMID: 27469583.
      View in: PubMed
    34. Kerstjens HA, Moroni-Zentgraf P, Tashkin D, Dahl R, Paggiaro P, Vandewalker M, Schmidt H, Engel M, Bateman ED. Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status. Respir Med. 2016 08; 117:198-206. PMID: 27492532.
      View in: PubMed
    35. Tkacova R, Dai DLY, Vonk JM, Leung JM, Hiemstra PS, van den Berge M, Kunz L, Hollander Z, Tashkin D, Wise R, Connett J, Ng R, McManus B, Paul Man SF, Postma DS, Sin DD. Airway hyperresponsiveness in chronic obstructive pulmonary disease: A marker of asthma-chronic obstructive pulmonary disease overlap syndrome? J Allergy Clin Immunol. 2016 Dec; 138(6):1571-1579.e10. PMID: 27345171.
      View in: PubMed
    36. Woodruff PG, Barr RG, Bleecker E, Christenson SA, Couper D, Curtis JL, Gouskova NA, Hansel NN, Hoffman EA, Kanner RE, Kleerup E, Lazarus SC, Martinez FJ, Paine R, Rennard S, Tashkin D, Han MK. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. N Engl J Med. 2016 May 12; 374(19):1811-21. PMID: 27168432; PMCID: PMC4968204 [Available on 11/12/16].
    37. Celli BR, Decramer M, Liu D, Metzdorf N, Asijee GM, Tashkin D. Defining a COPD composite safety endpoint for demonstrating efficacy in clinical trials: results from the randomized, placebo-controlled UPLIFT® trial. Respir Res. 2016 05 04; 17(1):48. PMID: 27141828; PMCID: PMC4855862.
    38. Tashkin D, Moore GE, Trudo F, DePietro M, Chipps BE. Assessment of Consistency of Fixed Airflow Obstruction Status during Budesonide/Formoterol Treatment and Its Effects on Treatment Outcomes in Patients with Asthma. J Allergy Clin Immunol Pract. 2016 Jul-Aug; 4(4):705-12. PMID: 27039236.
      View in: PubMed
    39. Nelson MD, Rezk-Hanna M, Rader F, Mason OR, Tang X, Shidban S, Rosenberry R, Benowitz NL, Tashkin D, Elashoff RM, Lindner JR, Victor RG. Acute Effect of Hookah Smoking on the Human Coronary Microcirculation. Am J Cardiol. 2016 Jun 01; 117(11):1747-54. PMID: 27067622.
      View in: PubMed
    40. Putcha N, Barr RG, Han MK, Woodruff PG, Bleecker ER, Kanner RE, Martinez FJ, Smith BM, Tashkin D, Bowler RP, Eisner MD, Rennard SI, Wise RA, Hansel NN. Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort. Thorax. 2016 Mar 09. PMID: 26962015.
      View in: PubMed
    41. Miles FL, Chang SC, Morgenstern H, Tashkin D, Rao JY, Cozen W, Mack T, Lu QY, Zhang ZF. Associations of red and processed meat with survival among patients with cancers of the upper aerodigestive tract and lung. Nutr Res. 2016 06; 36(6):620-6. PMID: 27188908.
      View in: PubMed
    42. Kim HJ, Tashkin D, Gjertson DW, Brown MS, Kleerup E, Chong S, Belperio JA, Roth MD, Abtin F, Elashoff R, Tseng CH, Khanna D, Goldin JG. Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment. Ann Rheum Dis. 2016 Jul; 75(7):1367-71. PMID: 26757749.
      View in: PubMed
    43. Khanna D, Nagaraja V, Tseng CH, Abtin F, Suh R, Kim G, Wells A, Furst DE, Clements PJ, Roth MD, Tashkin D, Goldin J. Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials. Arthritis Res Ther. 2015 Dec 23; 17:372. PMID: 26704522; PMCID: PMC4718035.
    44. Tashkin D. How beneficial is vaping cannabis to respiratory health compared to smoking? Addiction. 2015 Nov; 110(11):1706-7. PMID: 26471152.
      View in: PubMed
    45. Douglas IS, Albertson TE, Folan P, Hanania NA, Tashkin D, Upson DJ, Leone FT. Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup. Ann Am Thorac Soc. 2015 Nov; 12(11):1700-10. PMID: 26540421.
      View in: PubMed
    46. Assassi S, Swindell WR, Wu M, Tan FD, Khanna D, Furst DE, Tashkin D, Jahan-Tigh RR, Mayes MD, Gudjonsson JE, Chang JT. Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis. Arthritis Rheumatol. 2015 Nov; 67(11):3016-26. PMID: 26238292.
      View in: PubMed
    47. Rennard SI, Sin DD, Tashkin D, Calverley PM, Radner F. The Relationship among COPD Severity, Inhaled Corticosteroid Use, and the Risk of Pneumonia. Ann Am Thorac Soc. 2015 Oct; 12(10):1587-9. PMID: 26448356.
      View in: PubMed
    48. Tashkin D. The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease. Expert Opin Drug Saf. 2015; 14(11):1759-72. PMID: 26401729.
      View in: PubMed
    49. Tashkin D. Smoking Cessation in Chronic Obstructive Pulmonary Disease. Semin Respir Crit Care Med. 2015 Aug; 36(4):491-507. PMID: 26238637.
      View in: PubMed
    50. Tashkin D. Advances in Prevention and Treatment of Chronic Obstructive Pulmonary Disease. Semin Respir Crit Care Med. 2015 Aug; 36(4):455-6. PMID: 26238633.
      View in: PubMed
    51. Apperley S, Park HY, Holmes DT, Man SFP, Tashkin D, Wise RA, Connett JE, Sin DD. Serum Bilirubin and Disease Progression in Mild COPD. Chest. 2015 Jul; 148(1):169-175. PMID: 25539285; PMCID: PMC4493872.
    52. Tashkin D. The respiratory health benefits of quitting cannabis use. Eur Respir J. 2015 Jul; 46(1):1-4. PMID: 26130771.
      View in: PubMed
    53. Volkmann ER, Tashkin D, Li N, Furst DE, Clements PJ, Elashoff RM. Development of a Composite Outcome Measure for Systemic Sclerosis Related Interstitial Lung Disease. Rheumatology (Sunnyvale). 2015 Jun; 5(2). PMID: 28856069.
      View in: PubMed
    54. Halpin DMG, Tashkin D, Celli BR, Leimer I, Metzdorf N, Decramer M. Effect of Tiotropium on Outcomes in Patients With COPD, Categorized Using the New GOLD Grading System: Results of the UPLIFT® Randomized Controlled Trial. Chronic Obstr Pulm Dis. 2015 Jun 23; 2(3):236-251. PMID: 28848846.
      View in: PubMed
    55. Tashkin D, Leimer I, Metzdorf N, Decramer M. Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial. Respir Res. 2015 Jun 02; 16:65. PMID: 26031308; PMCID: PMC4475325.
    56. Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí AA, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin D, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. Eur Respir Rev. 2015 Jun; 24(136):159-72. PMID: 26028628.
      View in: PubMed
    57. Sze MA, Chen YW, Tam S, Tashkin D, Wise RA, Connett JE, Man SP, Sin DD. The relationship between Helicobacter pylori seropositivity and COPD. Thorax. 2015 Oct; 70(10):923-9. PMID: 26024688.
      View in: PubMed
    58. Anzueto A, Jenkins CR, Make BJ, Lindberg M, Calverley PM, Fagerås M, Postma DS, Rennard SI, Tashkin D. Efficacy of an inhaled corticosteroid/long-acting ß2-agonist combination in symptomatic COPD patients in GOLD groups B and D. Eur Respir J. 2015 Jul; 46(1):255-8. PMID: 26022947.
      View in: PubMed
    59. Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí A, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin D, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. Eur Respir J. 2015 Apr; 45(4):879-905. PMID: 25829431.
      View in: PubMed
    60. Celli BR, Decramer M, Wedzicha JA, Wilson KC, Agustí A, Criner GJ, MacNee W, Make BJ, Rennard SI, Stockley RA, Vogelmeier C, Anzueto A, Au DH, Barnes PJ, Burgel PR, Calverley PM, Casanova C, Clini EM, Cooper CB, Coxson HO, Dusser DJ, Fabbri LM, Fahy B, Ferguson GT, Fisher A, Fletcher MJ, Hayot M, Hurst JR, Jones PW, Mahler DA, Maltais F, Mannino DM, Martinez FJ, Miravitlles M, Meek PM, Papi A, Rabe KF, Roche N, Sciurba FC, Sethi S, Siafakas N, Sin DD, Soriano JB, Stoller JK, Tashkin D, Troosters T, Verleden GM, Verschakelen J, Vestbo J, Walsh JW, Washko GR, Wise RA, Wouters EF, ZuWallack RL. An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015 Apr 01; 191(7):e4-e27. PMID: 25830527.
      View in: PubMed
    61. Celli BR, Decramer M, Asijee GM, Kupas K, Tashkin D. Effects of Tiotropium on Exacerbations in Patients with COPD with Low or High Risk of Exacerbations: A Post-Hoc Analysis from the 4-Year UPLIFT® Trial. Chronic Obstr Pulm Dis. 2015 Mar 27; 2(2):122-130. PMID: 28848836.
      View in: PubMed
    62. Paulin LM, Diette GB, Blanc PD, Putcha N, Eisner MD, Kanner RE, Belli AJ, Christenson S, Tashkin D, Han M, Barr RG, Hansel NN. Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015 Mar 01; 191(5):557-65. PMID: 25562375; PMCID: PMC4384767.
    63. Tashkin D. Dual anti-inflammatory agents prevent COPD exacerbations. Lancet. 2015 Mar 07; 385(9971):832-4. PMID: 25684589.
      View in: PubMed
    64. Halpin DM, Dahl R, Hallmann C, Mueller A, Tashkin D. Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis. Int J Chron Obstruct Pulmon Dis. 2015; 10:239-59. PMID: 25709423; PMCID: PMC4332287.
    65. Tashkin D. Does marijuana pose risks for chronic airflow obstruction? Ann Am Thorac Soc. 2015 Feb; 12(2):235-6. PMID: 25706487; PMCID: PMC4342838.
    66. Berger WE, Tashkin D. Flunisolide hydrofluoroalkane with integrated spacer for treating asthma: an updated review. Allergy Asthma Proc. 2015 Mar-Apr; 36(2):105-15. PMID: 25635610.
      View in: PubMed
    67. Huang YH, Zhang ZF, Tashkin D, Feng B, Straif K, Hashibe M. An epidemiologic review of marijuana and cancer: an update. Cancer Epidemiol Biomarkers Prev. 2015 Jan; 24(1):15-31. PMID: 25587109; PMCID: PMC4302404.
    68. Donohue JF, Hanania NA, Make B, Miles MC, Mahler DA, Curry L, Tosiello R, Wheeler A, Tashkin D. One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD. Chest. 2014 Dec; 146(6):1531-1542. PMID: 25451347; PMCID: PMC4251615.
    69. Tashkin D, Volkmann ER, Tseng CH, Kim HJ, Goldin J, Clements P, Furst D, Khanna D, Kleerup E, Roth MD, Elashoff R. Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis. Ann Rheum Dis. 2016 Feb; 75(2):374-81. PMID: 25452309.
      View in: PubMed
    70. Tashkin D, Li N, Kleerup EC, Halpin D, Celli B, Decramer M, Elashoff R. Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD. Respir Res. 2014 Aug 31; 15:102. PMID: 25175805; PMCID: PMC4244051.
    71. Yang Y, Burke RV, Jeon CY, Chang SC, Chang PY, Morgenstern H, Tashkin D, Mao J, Cozen W, Mack TM, Rao J, Zhang ZF. Polymorphisms of peroxisome proliferator-activated receptors and survival of lung cancer and upper aero-digestive tract cancers. Lung Cancer. 2014 Sep; 85(3):449-56. PMID: 25043640.
      View in: PubMed
    72. Tashkin D. Increasing cannabis use: what we still need to know about its effects on the lung. Respirology. 2014 Jul; 19(5):619-20. PMID: 24862082.
      View in: PubMed
    73. Maspero J, Cherrez I, Doherty DE, Tashkin D, Kuna P, Kuo WL, Gates D, Nolte H, Chylack LT. Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma. Respir Med. 2014 Sep; 108(9):1355-62. PMID: 25044280.
      View in: PubMed
    74. Polosa R, Campagna D, Tashkin D. Subacute bronchial toxicity induced by an electronic cigarette: take home message. Thorax. 2014 Jun; 69(6):588. PMID: 24827822.
      View in: PubMed
    75. Streja L, Crespi CM, Bastani R, Wong GC, Jones CA, Bernert JT, Tashkin D, Hammond SK, Berman BA. Can a minimal intervention reduce secondhand smoke exposure among children with asthma from low income minority families? Results of a randomized trial. J Immigr Minor Health. 2014 Apr; 16(2):256-64. PMID: 22945813; PMCID: PMC3534823.
    76. Tashkin D, Chipps BE, Trudo F, Zangrilli JG. Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses. J Asthma. 2014 Aug; 51(6):603-9. PMID: 24524222; PMCID: PMC4162502.
    77. Park HY, Churg A, Wright JL, Li Y, Tam S, Man SF, Tashkin D, Wise RA, Connett JE, Sin DD. Club cell protein 16 and disease progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013 Dec 15; 188(12):1413-9. PMID: 24245748; PMCID: PMC3917377.
    78. Yang T, Chang PY, Park SL, Bastani D, Chang SC, Morgenstern H, Tashkin D, Mao JT, Papp JC, Rao JY, Cozen W, Mack TM, Greenland S, Zhang ZF. Tobacco smoking, NBS1 polymorphisms, and survival in lung and upper aerodigestive tract cancers with semi-Bayes adjustment for hazard ratio variation. Cancer Causes Control. 2014 Jan; 25(1):11-23. PMID: 24166361; PMCID: PMC3889468.
    79. Putcha N, Drummond MB, Connett JE, Scanlon PD, Tashkin D, Hansel NN, Wise RA. Chronic productive cough is associated with death in smokers with early COPD. COPD. 2014 Aug; 11(4):451-8. PMID: 24127996.
      View in: PubMed
    80. Tashkin D, Metzdorf N, Hallmann C, Leimer I, Lee T, Decramer M. Authors' response to Walker et al. Thorax. 2014 Apr; 69(4):385. PMID: 24127022.
      View in: PubMed
    81. Tashkin D. Roflumilast : the new orally active, selective phophodiesterase-4 inhibitor, for the treatment of COPD. Expert Opin Pharmacother. 2014 Jan; 15(1):85-96. PMID: 24032576.
      View in: PubMed
    82. Boiselle PM, Crapo JD, Han MK, Lynch DA, Tashkin D. Expert opinion: how can quantitative CT benefit patients with COPD and idiopathic interstitial pneumonias? J Thorac Imaging. 2013 Sep; 28(5):263. PMID: 23934143.
      View in: PubMed
    83. Tashkin D, Li N, Halpin D, Kleerup E, Decramer M, Celli B, Elashoff R. Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD. Respir Med. 2013 Dec; 107(12):1904-11. PMID: 23972968; PMCID: PMC4284059.
    84. Anzueto A, Niewoehner DE, Leimer I, Rühmkorf F, Celli BR, Decramer M, Tashkin D. A post hoc pooled analysis of exacerbations among US participants in randomized controlled trials of tiotropium. Respir Med. 2013 Dec; 107(12):1912-22. PMID: 23969305.
      View in: PubMed
    85. Gelb AF, Tashkin D, Make BJ, Zhong X, Garcia Gil E, Caracta C. Long-term safety and efficacy of twice-daily aclidinium bromide in patients with COPD. Respir Med. 2013 Dec; 107(12):1957-65. PMID: 23916502.
      View in: PubMed
    86. Tashkin D. Effects of marijuana smoking on the lung. Ann Am Thorac Soc. 2013 Jun; 10(3):239-47. PMID: 23802821.
      View in: PubMed
    87. Weiss DJ, Casaburi R, Flannery R, LeRoux-Williams M, Tashkin D. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest. 2013 Jun; 143(6):1590-1598. PMID: 23172272; PMCID: PMC4694112.
    88. Janssens W, Liu Y, Liu D, Kesten S, Tashkin D, Celli BR, Decramer M. Quality and reproducibility of spirometry in COPD patients in a randomized trial (UPLIFT®). Respir Med. 2013 Sep; 107(9):1409-16. PMID: 23714653.
      View in: PubMed
    89. Tashkin D, Ferguson GT. Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease. Respir Res. 2013 May 08; 14:49. PMID: 23651244; PMCID: PMC3651866.
    90. Park HY, Man SF, Tashkin D, Wise RA, Connett JE, Anthonisen NA, Sin DD. The relation of serum myeloperoxidase to disease progression and mortality in patients with chronic obstructive pulmonary disease (COPD). PLoS One. 2013; 8(4):e61315. PMID: 23637811; PMCID: PMC3630209.
    91. Sharafkhaneh A, Wolf RA, Goodnight S, Hanania NA, Make BJ, Tashkin D. Perceptions and attitudes toward the use of nebulized therapy for COPD: patient and caregiver perspectives. COPD. 2013 Aug; 10(4):482-92. PMID: 23875742.
      View in: PubMed
    92. Tashkin D. Variations in FEV1 decline over time in chronic obstructive pulmonary disease and its implications. Curr Opin Pulm Med. 2013 Mar; 19(2):116-24. PMID: 23287286.
      View in: PubMed
    93. Tashkin D. Future of fixed-dose longacting ß2-agonist and antimuscarinic combination therapy in COPD. Lancet Respir Med. 2013 Mar; 1(1):6-7. PMID: 24321790.
      View in: PubMed
    94. Yoon HI, Li Y, Man SFP, Tashkin D, Wise RA, Connett JE, Anthonisen NA, Churg A, Wright JL, Sin DD. The complex relationship of serum adiponectin to COPD outcomes COPD and adiponectin. Chest. 2012 Oct; 142(4):893-899. PMID: 22207678.
      View in: PubMed
    95. Halpin DM, Decramer M, Celli B, Kesten S, Liu D, Tashkin D. Exacerbation frequency and course of COPD. Int J Chron Obstruct Pulmon Dis. 2012; 7:653-61. PMID: 23055714; PMCID: PMC3459660.
    96. Tashkin D, Rabinoff M, Noble EP, Ritchie TL, Simmons MS, Connett J. Association of dopamine-related gene alleles, smoking behavior and decline in FEV1 in subjects with COPD: findings from the lung health study. COPD. 2012 Dec; 9(6):620-8. PMID: 22958175.
      View in: PubMed
    97. Theodore AC, Tseng CH, Li N, Elashoff RM, Tashkin D. Correlation of cough with disease activity and treatment with cyclophosphamide in scleroderma interstitial lung disease: findings from the Scleroderma Lung Study. Chest. 2012 Sep; 142(3):614-621. PMID: 22156609; PMCID: PMC3435135.
    98. Tashkin D, Wang HJ, Halpin D, Kleerup EC, Connett J, Li N, Elashoff R. Comparison of the variability of the annual rates of change in FEV1 determined from serial measurements of the pre- versus post-bronchodilator FEV1 over 5 years in mild to moderate COPD: results of the lung health study. Respir Res. 2012 Aug 15; 13:70. PMID: 22894725; PMCID: PMC3439318.
    99. Celli BR, Decramer M, Lystig T, Kesten S, Tashkin D. Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease. Respir Res. 2012 Aug 06; 13:66. PMID: 22866681; PMCID: PMC3443002.
    100. Tashkin D. Is it asthma, COPD, or something in between, and does it matter? Respir Care. 2012 Aug; 57(8):1354-6. PMID: 22867646.
      View in: PubMed
    101. Baay-Guzman GJ, Bebenek IG, Zeidler M, Hernandez-Pando R, Vega MI, Garcia-Zepeda EA, Antonio-Andres G, Bonavida B, Riedl M, Kleerup E, Tashkin D, Hankinson O, Huerta-Yepez S. HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: implications in allergic airway inflammation. Respir Res. 2012 Jul 23; 13:60. PMID: 22823210; PMCID: PMC3439306.
    102. Drummond MB, Hansel NN, Connett JE, Scanlon PD, Tashkin D, Wise RA. Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012 Jun 15; 185(12):1301-6. PMID: 22561963.
      View in: PubMed
    103. Tashkin D, Simmons MS, Tseng CH. Impact of changes in regular use of marijuana and/or tobacco on chronic bronchitis. COPD. 2012 Aug; 9(4):367-74. PMID: 22497563.
      View in: PubMed
    104. Brown MS, Kim HJ, Abtin FG, Strange C, Galperin-Aizenberg M, Pais R, Da Costa IG, Ordookhani A, Chong D, Ni C, McNitt-Gray MF, Tashkin D, Goldin JG. Emphysema lung lobe volume reduction: effects on the ipsilateral and contralateral lobes. Eur Radiol. 2012 Jul; 22(7):1547-55. PMID: 22466511.
      View in: PubMed
    105. Tashkin D, Celli BR, Decramer M, Lystig T, Liu D, Kesten S. Efficacy of tiotropium in COPD patients with FEV1 = 60% participating in the UPLIFT® trial. COPD. 2012 Jun; 9(3):289-96. PMID: 22432932.
      View in: PubMed
    106. Tarleton HP, Park SL, Zhu WM, Lee YC, Hashibe M, Morgenstern H, Tashkin D, Mao JT, Cozen W, Mack TM, Zhang ZF. Body mass index change in adulthood and lung and upper aerodigestive tract cancers. Int J Cancer. 2012 Sep 15; 131(6):1407-16. PMID: 22131048; PMCID: PMC3402653.
    107. Tashkin D, Doherty DE, Kerwin E, Matiz-Bueno CE, Knorr B, Shekar T, Gates D, Staudinger H. Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials. Int J Chron Obstruct Pulmon Dis. 2012; 7:73-86. PMID: 22334770; PMCID: PMC3276258.
    108. Doherty DE, Tashkin D, Kerwin E, Knorr BA, Shekar T, Banerjee S, Staudinger H. Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD. Int J Chron Obstruct Pulmon Dis. 2012; 7:57-71. PMID: 22334769; PMCID: PMC3276257.
    109. Tashkin D, Doherty DE, Kerwin E, Matiz-Bueno CE, Knorr B, Shekar T, Banerjee S, Staudinger H. Efficacy and safety of a fixed-dose combination of mometasone furoate and formoterol fumarate in subjects with moderate to very severe COPD: results from a 52-week Phase III trial. Int J Chron Obstruct Pulmon Dis. 2012; 7:43-55. PMID: 22334768; PMCID: PMC3276256.
    110. Tashkin D. COPD Progression and individual rates of change in FEV1 and the BODE index. Am J Respir Crit Care Med. 2011 Nov 01; 184(9):988-90. PMID: 22045742.
      View in: PubMed
    111. Khanna D, Tseng CH, Farmani N, Steen V, Furst DE, Clements PJ, Roth MD, Goldin J, Elashoff R, Seibold JR, Saggar R, Tashkin D. Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group. Arthritis Rheum. 2011 Oct; 63(10):3078-85. PMID: 21618205; PMCID: PMC3183128.
    112. Kesten S, Celli B, Decramer M, Liu D, Tashkin D. Adverse health consequences in COPD patients with rapid decline in FEV1--evidence from the UPLIFT trial. Respir Res. 2011 Sep 28; 12:129. PMID: 21955733; PMCID: PMC3190346.
    113. Tashkin D. ß-blockers associated with reduced all-cause mortality in COPD. Evid Based Med. 2012 Feb; 17(1):31-2. PMID: 21949256.
      View in: PubMed
    114. Kim HJ, Brown MS, Elashoff R, Li G, Gjertson DW, Lynch DA, Strollo DC, Kleerup E, Chong D, Shah SK, Ahmad S, Abtin F, Tashkin D, Goldin JG. Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide. Eur Radiol. 2011 Dec; 21(12):2455-65. PMID: 21927793.
      View in: PubMed
    115. Roth MD, Tseng CH, Clements PJ, Furst DE, Tashkin D, Goldin JG, Khanna D, Kleerup EC, Li N, Elashoff D, Elashoff RM. Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease. Arthritis Rheum. 2011 Sep; 63(9):2797-808. PMID: 21547897; PMCID: PMC3910296.
    116. Fukuchi Y, Fernandez L, Kuo HP, Mahayiddin A, Celli B, Decramer M, Kesten S, Liu D, Tashkin D. Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial. Respirology. 2011 Jul; 16(5):825-35. PMID: 21539680.
      View in: PubMed
    117. Mao JT, Roth MD, Fishbein MC, Aberle DR, Zhang ZF, Rao JY, Tashkin D, Goodglick L, Holmes EC, Cameron RB, Dubinett SM, Elashoff R, Szabo E, Elashoff D. Lung cancer chemoprevention with celecoxib in former smokers. Cancer Prev Res (Phila). 2011 Jul; 4(7):984-93. PMID: 21733822; PMCID: PMC3153413.
    118. Halpin DM, Decramer M, Celli B, Kesten S, Leimer I, Tashkin D. Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT® trial. Lung. 2011 Aug; 189(4):261-8. PMID: 21678045; PMCID: PMC3140935.
    119. Hill J, Heslop C, Man SF, Frohlich J, Connett JE, Anthonisen NR, Wise RA, Tashkin D, Sin DD. Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality. Eur Heart J. 2011 Aug; 32(15):1918-25. PMID: 21653561.
      View in: PubMed
    120. Tashkin D, Rennard S, Taylor Hays J, Lawrence D, Marton JP, Lee TC. Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients. Respir Med. 2011 Nov; 105(11):1682-90. PMID: 21621992.
      View in: PubMed
    121. Cooper CB, Anzueto A, Decramer M, Celli B, Tashkin D, Leimer I, Kesten S. Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials. Int J Chron Obstruct Pulmon Dis. 2011; 6:269-75. PMID: 21845038; PMCID: PMC3152465.
    122. Decramer M, Molenberghs G, Liu D, Celli B, Kesten S, Lystig T, Tashkin D. Premature discontinuation during the UPLIFT study. Respir Med. 2011 Oct; 105(10):1523-30. PMID: 21530213.
      View in: PubMed
    123. Furst DE, Tseng CH, Clements PJ, Strange C, Tashkin D, Roth MD, Khanna D, Li N, Elashoff R, Schraufnagel DE. Adverse events during the Scleroderma Lung Study. Am J Med. 2011 May; 124(5):459-67. PMID: 21531236.
      View in: PubMed
    124. Celli BR, Tashkin D, Rennard SI, McElhattan J, Martin UJ. Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD. Respir Med. 2011 Aug; 105(8):1176-88. PMID: 21531124.
      View in: PubMed
    125. Huerta-Yepez S, Baay-Guzman GJ, Bebenek IG, Hernandez-Pando R, Vega MI, Chi L, Riedl M, Diaz-Sanchez D, Kleerup E, Tashkin D, Gonzalez FJ, Bonavida B, Zeidler M, Hankinson O. Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis. Allergy. 2011 Jul; 66(7):909-18. PMID: 21517900; PMCID: PMC3107385.
    126. Hatsukami DK, Jorenby DE, Gonzales D, Rigotti NA, Glover ED, Oncken CA, Tashkin D, Reus VI, Akhavain RC, Fahim RE, Kessler PD, Niknian M, Kalnik MW, Rennard SI. Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther. 2011 Mar; 89(3):392-9. PMID: 21270788; PMCID: PMC4106715.
    127. Hanania NA, Sharafkhaneh A, Celli B, Decramer M, Lystig T, Kesten S, Tashkin D. Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respir Res. 2011 Jan 11; 12:6. PMID: 21219660; PMCID: PMC3027109.
    128. Sin DD, Miller BE, Duvoix A, Man SF, Zhang X, Silverman EK, Connett JE, Anthonisen NA, Wise RA, Tashkin D, Celli BR, Edwards LD, Locantore N, Macnee W, Tal-Singer R, Lomas DA. Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011 May 01; 183(9):1187-92. PMID: 21216880; PMCID: PMC3114051.
    129. Tashkin D. Budesonide and formoterol in a single pressurized metered-dose inhaler for treatment of COPD. Expert Rev Respir Med. 2010 Dec; 4(6):703-14. PMID: 21128746.
      View in: PubMed
    130. Au K, Mayes MD, Maranian P, Clements PJ, Khanna D, Steen VD, Tashkin D, Roth MD, Elashoff R, Furst DE. Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung study. Arthritis Care Res (Hoboken). 2010 Dec; 62(12):1772-8. PMID: 20740615; PMCID: PMC2994974.
    131. Kim HG, Tashkin D, Clements PJ, Li G, Brown MS, Elashoff R, Gjertson DW, Abtin F, Lynch DA, Strollo DC, Goldin JG. A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients. Clin Exp Rheumatol. 2010 Sep-Oct; 28(5 Suppl 62):S26-35. PMID: 21050542; PMCID: PMC3177564.
    132. Oh SS, Chang SC, Cai L, Cordon-Cardo C, Ding BG, Greenland S, He N, Jiang Q, Kheifets L, Le A, Lee YC, Liu S, Lu ML, Mao JT, Morgenstern H, Mu LN, Pantuck A, Papp JC, Park SL, Rao JY, Reuter VE, Tashkin D, Wang H, You NC, Yu SZ, Zhao JK, Belldegrun A, Zhang ZF. Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancers. Int J Cancer. 2010 Nov 01; 127(9):2169-82. PMID: 20112337; PMCID: PMC2932751.
    133. Tashkin D, Fabbri LM. Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents. Respir Res. 2010 Oct 29; 11:149. PMID: 21034447; PMCID: PMC2991288.
    134. Bateman ED, Tashkin D, Siafakas N, Dahl R, Towse L, Massey D, Pavia D, Zhong NS. A one-year trial of tiotropium Respimat plus usual therapy in COPD patients. Respir Med. 2010 Oct; 104(10):1460-72. PMID: 20620037.
      View in: PubMed
    135. Tashkin D, Rennard S, Hays JT, Ma W, Lawrence D, Lee TC. Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial. Chest. 2011 Mar; 139(3):591-599. PMID: 20864613.
      View in: PubMed
    136. Tashkin D. Frequent exacerbations of chronic obstructive pulmonary disease--a distinct phenotype? N Engl J Med. 2010 Sep 16; 363(12):1183-4. PMID: 20843256.
      View in: PubMed
    137. Morice AH, Celli B, Kesten S, Lystig T, Tashkin D, Decramer M. COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT). Respir Med. 2010 Nov; 104(11):1659-67. PMID: 20724131.
      View in: PubMed
    138. Copersino ML, Boyd SJ, Tashkin D, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Sociodemographic characteristics of cannabis smokers and the experience of cannabis withdrawal. Am J Drug Alcohol Abuse. 2010 Nov; 36(6):311-9. PMID: 20678028; PMCID: PMC3197209.
    139. Tashkin D. Indacaterol maleate for the treatment of chronic obstructive pulmonary disease. Expert Opin Pharmacother. 2010 Aug; 11(12):2077-85. PMID: 20642373.
      View in: PubMed
    140. Tashkin D, Varghese ST. Combined treatment with formoterol and tiotropium is more efficacious than treatment with tiotropium alone in patients with chronic obstructive pulmonary disease, regardless of smoking status, inhaled corticosteroid use, baseline severity, or gender. Pulm Pharmacol Ther. 2011 Feb; 24(1):147-52. PMID: 20659577.
      View in: PubMed
    141. Khanna D, Brown KK, Clements PJ, Elashoff R, Furst DE, Goldin J, Seibold JR, Silver RM, Tashkin D, Wells AU. Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials. Clin Exp Rheumatol. 2010 Mar-Apr; 28(2 Suppl 58):S55-62. PMID: 20576216.
      View in: PubMed
    142. Zeidler M, Corren J, Tashkin D. Use of mometasone furoate administered via a dry powder inhaler in the treatment of asthma. Curr Med Res Opin. 2010 Jun; 26(6):1295-305. PMID: 20370376.
      View in: PubMed
    143. Tashkin D. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial. Expert Rev Respir Med. 2010 Jun; 4(3):279-89. PMID: 20524910.
      View in: PubMed
    144. Park SL, Bastani D, Goldstein BY, Chang SC, Cozen W, Cai L, Cordon-Cardo C, Ding B, Greenland S, He N, Hussain SK, Jiang Q, Lee YC, Liu S, Lu ML, Mack TM, Mao JT, Morgenstern H, Mu LN, Oh SS, Pantuck A, Papp JC, Rao J, Reuter VE, Tashkin D, Wang H, You NC, Yu SZ, Zhao JK, Zhang ZF. Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers. Carcinogenesis. 2010 Jul; 31(7):1264-71. PMID: 20478923; PMCID: PMC2893801.
    145. O'Connor RD, Bleecker ER, Long A, Tashkin D, Peters S, Klingman D, Gutierrez B. Subacute lack of asthma control and acute asthma exacerbation history as predictors of subsequent acute asthma exacerbations: evidence from managed care data. J Asthma. 2010 May; 47(4):422-8. PMID: 20528597.
      View in: PubMed
    146. Tashkin D, Celli B, Kesten S, Lystig T, Decramer M. Effect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trial. Respir Med. 2010 Oct; 104(10):1495-504. PMID: 20418083.
      View in: PubMed
    147. Tashkin D. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety. Curr Opin Pulm Med. 2010 Mar; 16(2):97-105. PMID: 20019615.
      View in: PubMed
    148. Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin D, Decramer M. Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. Eur Respir J. 2010 Jul; 36(1):65-73. PMID: 20185426.
      View in: PubMed
    149. Tashkin D. Preventing and managing exacerbations in COPD--critical appraisal of the role of tiotropium. Int J Chron Obstruct Pulmon Dis. 2010 Feb 18; 5:41-53. PMID: 20368910; PMCID: PMC2846152.
    150. Tashkin D. Does cannabis use predispose to chronic airflow obstruction? Eur Respir J. 2010 Jan; 35(1):3-5. PMID: 20044454.
      View in: PubMed
    151. Tashkin D, Hanania NA, McGinty J, Denis-Mize K, Chaudry I. Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease. Adv Ther. 2009 Nov; 26(11):1024-34. PMID: 19953349.
      View in: PubMed
    152. Tashkin D, de Lange EE. Imaging of the distal airways. J Allergy Clin Immunol. 2009 Dec; 124(6 Suppl):S78-83. PMID: 19962040; PMCID: PMC2804062.
    153. Kesten S, Celli B, Decramer M, Leimer I, Tashkin D. Tiotropium HandiHaler in the treatment of COPD: a safety review. Int J Chron Obstruct Pulmon Dis. 2009; 4:397-409. PMID: 20037679; PMCID: PMC2793068.
    154. Goldin J, Elashoff R, Kim HJ, Yan X, Lynch D, Strollo D, Roth MD, Clements P, Furst DE, Khanna D, Vasunilashorn S, Li G, Tashkin D. Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study. Chest. 2009 Nov; 136(5):1333-1340. PMID: 19892673; PMCID: PMC2773360.
    155. Cazzola M, Tashkin D. Combination of formoterol and tiotropium in the treatment of COPD: effects on lung function. COPD. 2009 Oct; 6(5):404-15. PMID: 19863370.
      View in: PubMed
    156. Khanna D, Tseng CH, Furst DE, Clements PJ, Elashoff R, Roth M, Elashoff D, Tashkin D. Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial--results from the Scleroderma Lung Study. Rheumatology (Oxford). 2009 Dec; 48(12):1537-40. PMID: 19776222; PMCID: PMC2777487.
    157. Celli B, Decramer M, Kesten S, Liu D, Mehra S, Tashkin D. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009 Nov 15; 180(10):948-55. PMID: 19729663.
      View in: PubMed
    158. Sin DD, Tashkin D, Zhang X, Radner F, Sjöbring U, Thorén A, Calverley PM, Rennard SI. Budesonide and the risk of pneumonia: a meta-analysis of individual patient data. Lancet. 2009 Aug 29; 374(9691):712-9. PMID: 19716963.
      View in: PubMed
    159. Tashkin D, Celli B, Kesten S, Lystig T, Mehra S, Decramer M. Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial. Eur Respir J. 2010 Feb; 35(2):287-94. PMID: 19717481.
      View in: PubMed
    160. Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin D. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet. 2009 Oct 03; 374(9696):1171-8. PMID: 19716598.
      View in: PubMed
    161. Celli B, Decramer M, Leimer I, Vogel U, Kesten S, Tashkin D. Cardiovascular safety of tiotropium in patients with COPD. Chest. 2010 Jan; 137(1):20-30. PMID: 19592475.
      View in: PubMed
    162. Kye SH, Tashkin D, Roth MD, Adams B, Nie WX, Mao JT. Recruitment strategies for a lung cancer chemoprevention trial involving ex-smokers. Contemp Clin Trials. 2009 Sep; 30(5):464-72. PMID: 19508900.
      View in: PubMed
    163. Halpin DM, Tashkin D. Defining disease modification in chronic obstructive pulmonary disease. COPD. 2009 Jun; 6(3):211-25. PMID: 19811377; PMCID: PMC2699950.
    164. Tashkin D. Does smoking marijuana increase the risk of chronic obstructive pulmonary disease? CMAJ. 2009 Apr 14; 180(8):797-8. PMID: 19364782; PMCID: PMC2665954.
    165. Au K, Khanna D, Clements PJ, Furst DE, Tashkin D. Current concepts in disease-modifying therapy for systemic sclerosis-associated interstitial lung disease: lessons from clinical trials. Curr Rheumatol Rep. 2009 Apr; 11(2):111-9. PMID: 19296883.
      View in: PubMed
    166. Tashkin D, Murray RP. Smoking cessation in chronic obstructive pulmonary disease. Respir Med. 2009 Jul; 103(7):963-74. PMID: 19285850.
      View in: PubMed
    167. Hant FN, Ludwicka-Bradley A, Wang HJ, Li N, Elashoff R, Tashkin D, Silver RM. Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma. J Rheumatol. 2009 Apr; 36(4):773-80. PMID: 19286849.
      View in: PubMed
    168. Tashkin D, Donohue JF, Mahler DA, Huang H, Goodwin E, Schaefer K, Hanrahan JP, Andrews WT. Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD. Respir Med. 2009 Apr; 103(4):516-24. PMID: 19208459.
      View in: PubMed
    169. Chao C, Jacobson LP, Jenkins FJ, Tashkin D, Martínez-Maza O, Roth MD, Ng L, Margolick JB, Chmiel JS, Zhang ZF, Detels R. Recreational drug use and risk of Kaposi's sarcoma in HIV- and HHV-8-coinfected homosexual men. AIDS Res Hum Retroviruses. 2009 Feb; 25(2):149-56. PMID: 19108691; PMCID: PMC2981355.
    170. Tashkin D, Pearle J, Iezzoni D, Varghese ST. Formoterol and tiotropium compared with tiotropium alone for treatment of COPD. COPD. 2009 Feb; 6(1):17-25. PMID: 19229704.
      View in: PubMed
    171. Rennard SI, Tashkin D, McElhattan J, Goldman M, Ramachandran S, Martin UJ, Silkoff PE. Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial. Drugs. 2009; 69(5):549-65. PMID: 19368417; PMCID: PMC3580134.
    172. Tashkin D, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M. A 4-year trial of tiotropium in chronic obstructive pulmonary disease (UPLIFT trial). Rev Port Pneumol. 2009 Jan-Feb; 15(1):137-40. PMID: 25965528.
      View in: PubMed
    173. Tashkin D. The role of tiotropium in the hospital management of exacerbation of chronic obstructive pulmonary disease. Respir Care. 2008 Dec; 53(12):1657-9. PMID: 19025697.
      View in: PubMed
    174. Chao C, Jacobson LP, Tashkin D, Martínez-Maza O, Roth MD, Margolick JB, Chmiel JS, Holloway MN, Zhang ZF, Detels R. Recreational amphetamine use and risk of HIV-related non-Hodgkin lymphoma. Cancer Causes Control. 2009 Jul; 20(5):509-16. PMID: 19011979; PMCID: PMC2862618.
    175. Park SL, Chang SC, Cai L, Cordon-Cardo C, Ding BG, Greenland S, Hussain SK, Jiang Q, Liu S, Lu ML, Mao JT, Morgenstern H, Mu LN, Ng LJ, Pantuck A, Rao J, Reuter VE, Tashkin D, You NC, Yu CQ, Yu SZ, Zhao JK, Belldegrun A, Zhang ZF. Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):3193-202. PMID: 18990762; PMCID: PMC2664075.
    176. Tashkin D, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008 Oct 09; 359(15):1543-54. PMID: 18836213.
      View in: PubMed
    177. Weigt SS, Abrazado M, Kleerup EC, Tashkin D, Cooper CB. Time course and degree of hyperinflation with metronome-paced tachypnea in COPD patients. COPD. 2008 Oct; 5(5):298-304. PMID: 18972278.
      View in: PubMed
    178. Dubinett SM, Aberle DR, Tashkin D, Mao JT. The partners--airflow obstruction, emphysema, and lung cancer. Am J Respir Crit Care Med. 2008 Oct 01; 178(7):665-6. PMID: 18796652.
      View in: PubMed
    179. Man SF, Xing L, Connett JE, Anthonisen NR, Wise RA, Tashkin D, Zhang X, Vessey R, Walker TG, Celli BR, Sin DD. Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Eur Respir J. 2008 Dec; 32(6):1451-7. PMID: 18799503.
      View in: PubMed
    180. Mao JT, Tashkin D, Tsu IH, Serio KJ. Differential modulation of leukotriene B4 synthesis and degradation in human bronchoalveolar lavage cells by lipopolysaccharide and tobacco smoke. Cancer Prev Res (Phila). 2008 Sep; 1(4):266-74. PMID: 19138970.
      View in: PubMed
    181. Goldin JG, Lynch DA, Strollo DC, Suh RD, Schraufnagel DE, Clements PJ, Elashoff RM, Furst DE, Vasunilashorn S, McNitt-Gray MF, Brown MS, Roth MD, Tashkin D. High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest. 2008 Aug; 134(2):358-367. PMID: 18641099.
      View in: PubMed
    182. Tashkin D, Celli B, Decramer M, Liu D, Burkhart D, Cassino C, Kesten S. Bronchodilator responsiveness in patients with COPD (data from the UPLIFT trial). Rev Port Pneumol. 2008 Jul-Aug; 14(4):584-7. PMID: 25967078.
      View in: PubMed
    183. Cui Y, Morgenstern H, Greenland S, Tashkin D, Mao JT, Cai L, Cozen W, Mack TM, Lu QY, Zhang ZF. Dietary flavonoid intake and lung cancer--a population-based case-control study. Cancer. 2008 May 15; 112(10):2241-8. PMID: 18327817.
      View in: PubMed
    184. Khanna D, Furst DE, Clements PJ, Tashkin D, Eckman MH. Oral cyclophosphamide for active scleroderma lung disease: a decision analysis. Med Decis Making. 2008 Nov-Dec; 28(6):926-37. PMID: 18443209.
      View in: PubMed
    185. Lee YC, Morgenstern H, Greenland S, Tashkin D, Papp J, Sinsheimer J, Cao W, Hashibe M, You NC, Mao JT, Cozen W, Mack TM, Zhang ZF. A case-control study of the association of the polymorphisms and haplotypes of DNA ligase I with lung and upper-aerodigestive-tract cancers. Int J Cancer. 2008 Apr 01; 122(7):1630-8. PMID: 18059021; PMCID: PMC2676936.
    186. Tashkin D, Littner M, Andrews CP, Tomlinson L, Rinehart M, Denis-Mize K. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial. Respir Med. 2008 Apr; 102(4):479-87. PMID: 18258423.
      View in: PubMed
    187. Tashkin D, Celli B, Decramer M, Liu D, Burkhart D, Cassino C, Kesten S. Bronchodilator responsiveness in patients with COPD. Eur Respir J. 2008 Apr; 31(4):742-50. PMID: 18256071.
      View in: PubMed
    188. Sakkour A, Wang T, Tashkin D. A 56-year-old woman with COPD and multiple pulmonary nodules. Chest. 2008 Feb; 133(2):566-9. PMID: 18252924.
      View in: PubMed
    189. Chao C, Jacobson LP, Tashkin D, Martínez-Maza O, Roth MD, Margolick JB, Chmiel JS, Rinaldo C, Zhang ZF, Detels R. Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected men. Drug Alcohol Depend. 2008 Apr 01; 94(1-3):165-71. PMID: 18180115; PMCID: PMC2691391.
    190. Tashkin D, Rennard SI, Martin P, Ramachandran S, Martin UJ, Silkoff PE, Goldman M. Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial. Drugs. 2008; 68(14):1975-2000. PMID: 18778120.
      View in: PubMed
    191. Tashkin D. Oral vs IV corticosteroids for in-hospital treatment of COPD exacerbations. Chest. 2007 Dec; 132(6):1728-9. PMID: 18079214.
      View in: PubMed
    192. Bailey WC, Tashkin D. Pharmacologic therapy: novel approaches for chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007 Oct 01; 4(7):543-8. PMID: 17878467.
      View in: PubMed
    193. Strange C, Bolster MB, Roth MD, Silver RM, Theodore A, Goldin J, Clements P, Chung J, Elashoff RM, Suh R, Smith EA, Furst DE, Tashkin D. Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med. 2008 Jan 01; 177(1):91-8. PMID: 17901414; PMCID: PMC2176114.
    194. Tashkin D, Elashoff R, Clements PJ, Roth MD, Furst DE, Silver RM, Goldin J, Arriola E, Strange C, Bolster MB, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel D, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Khanna D, Li N, Li G. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med. 2007 Nov 15; 176(10):1026-34. PMID: 17717203; PMCID: PMC2078679.
    195. Wise RA, Tashkin D. Preventing chronic obstructive pulmonary disease: what is known and what needs to be done to make a difference to the patient? Am J Med. 2007 Aug; 120(8 Suppl 1):S14-22. PMID: 17678939.
      View in: PubMed
    196. Wise RA, Tashkin D. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies. Am J Med. 2007 Aug; 120(8 Suppl 1):S4-13. PMID: 17678942.
      View in: PubMed
    197. Harber P, Tashkin D, Simmons M, Crawford L, Hnizdo E, Connett J. Effect of occupational exposures on decline of lung function in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007 Nov 15; 176(10):994-1000. PMID: 17626912; PMCID: PMC2078677.
    198. Clements PJ, Roth MD, Elashoff R, Tashkin D, Goldin J, Silver RM, Sterz M, Seibold JR, Schraufnagel D, Simms RW, Bolster M, Wise RA, Steen V, Mayes MD, Connelly K, Metersky M, Furst DE. Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis. Ann Rheum Dis. 2007 Dec; 66(12):1641-7. PMID: 17485423; PMCID: PMC2095310.
    199. Tashkin D, Klein GL, Colman SS, Zayed H, Schonfeld WH. Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy. Am J Med. 2007 May; 120(5):435-41. PMID: 17466655.
      View in: PubMed
    200. Khanna D, Yan X, Tashkin D, Furst DE, Elashoff R, Roth MD, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Clements PJ. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study. Arthritis Rheum. 2007 May; 56(5):1676-84. PMID: 17469162.
      View in: PubMed
    201. Murray RP, Connett JE, Skeans MA, Tashkin D. Menthol cigarettes and health risks in Lung Health Study data. Nicotine Tob Res. 2007 Jan; 9(1):101-7. PMID: 17365741.
      View in: PubMed
    202. Hashibe M, Morgenstern H, Cui Y, Tashkin D, Zhang ZF, Cozen W, Mack TM, Greenland S. Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2006 Oct; 15(10):1829-34. PMID: 17035389.
      View in: PubMed
    203. Tashkin D. The role of patient-centered outcomes in defining the clinical course of chronic obstructive pulmonary disease. Introduction. Am J Med. 2006 Oct; 119(10 Suppl 1):1-3. PMID: 16996893.
      View in: PubMed
    204. Tashkin D. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding. Am J Med. 2006 Oct; 119(10 Suppl 1):63-72. PMID: 16996901.
      View in: PubMed
    205. Rutten-van Mölken MP, Oostenbrink JB, Tashkin D, Burkhart D, Monz BU. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest. 2006 Oct; 130(4):1117-28. PMID: 17035446.
      View in: PubMed
    206. Zeidler MR, Goldin JG, Kleerup EC, Kim HJ, Truong DA, Gjertson DW, Kennedy NJ, Newman KB, Tashkin D, Silverman JM, Corren J. Small airways response to naturalistic cat allergen exposure in subjects with asthma. J Allergy Clin Immunol. 2006 Nov; 118(5):1075-81. PMID: 17088132.
      View in: PubMed
    207. Cole JC, Khanna D, Clements PJ, Seibold JR, Tashkin D, Paulus HE, Irwin MR, Motivala SJ, Furst DE. Single-factor scoring validation for the Health Assessment Questionnaire-Disability Index (HAQ-DI) in patients with systemic sclerosis and comparison with early rheumatoid arthritis patients. Qual Life Res. 2006 Oct; 15(8):1383-94. PMID: 16826439.
      View in: PubMed
    208. Copersino ML, Boyd SJ, Tashkin D, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Quitting among non-treatment-seeking marijuana users: reasons and changes in other substance use. Am J Addict. 2006 Jul-Aug; 15(4):297-302. PMID: 16867925.
      View in: PubMed
    209. Tashkin D, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med. 2006 Jun 22; 354(25):2655-66. PMID: 16790698.
      View in: PubMed
    210. Jarjour NN, Wilson SJ, Koenig SM, Laviolette M, Moore WC, Davis WB, Doherty DE, Hamid Q, Israel E, Kavuru MS, Ramsdell JW, Tashkin D, Reilly DS, Yancey SW, Edwards LD, Stauffer JL, Dorinsky PM, Djukanovic R. Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol. J Allergy Clin Immunol. 2006 Jul; 118(1):44-52. PMID: 16815137.
      View in: PubMed
    211. Man SF, Connett JE, Anthonisen NR, Wise RA, Tashkin D, Sin DD. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax. 2006 Oct; 61(10):849-53. PMID: 16738034; PMCID: PMC2104755.
    212. Fligiel SE, Standiford T, Fligiel HM, Tashkin D, Strieter RM, Warner RL, Johnson KJ, Varani J. Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury. Hum Pathol. 2006 Apr; 37(4):422-30. PMID: 16564916.
      View in: PubMed
    213. Zeidler MR, Kleerup EC, Goldin JG, Kim HJ, Truong DA, Simmons MD, Sayre JW, Liu W, Elashoff R, Tashkin D. Montelukast improves regional air-trapping due to small airways obstruction in asthma. Eur Respir J. 2006 Feb; 27(2):307-15. PMID: 16452585.
      View in: PubMed
    214. Cui Y, Morgenstern H, Greenland S, Tashkin D, Mao J, Cao W, Cozen W, Mack TM, Zhang ZF. Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus. Int J Cancer. 2006 Feb 01; 118(3):714-20. PMID: 16094634.
      View in: PubMed
    215. Sarafian TA, Habib N, Oldham M, Seeram N, Lee RP, Lin L, Tashkin D, Roth MD. Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo. Am J Physiol Lung Cell Mol Physiol. 2006 Jun; 290(6):L1202-9. PMID: 16414979.
      View in: PubMed
    216. Copersino ML, Boyd SJ, Tashkin D, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Cannabis withdrawal among non-treatment-seeking adult cannabis users. Am J Addict. 2006 Jan-Feb; 15(1):8-14. PMID: 16449088.
      View in: PubMed
    217. Mao JT, Fishbein MC, Adams B, Roth MD, Goodglick L, Hong L, Burdick M, Strieter ER, Holmes C, Tashkin D, Dubinett SM. Celecoxib decreases Ki-67 proliferative index in active smokers. Clin Cancer Res. 2006 Jan 01; 12(1):314-20. PMID: 16397057.
      View in: PubMed
    218. Roth MD, Whittaker KM, Choi R, Tashkin D, Baldwin GC. Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model. J Leukoc Biol. 2005 Dec; 78(6):1198-203. PMID: 16204638.
      View in: PubMed
    219. Roth MD, Tashkin D, Whittaker KM, Choi R, Baldwin GC. Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse. Life Sci. 2005 Aug 19; 77(14):1711-22. PMID: 15964028.
      View in: PubMed
    220. Anthonisen NR, Lindgren PG, Tashkin D, Kanner RE, Scanlon PD, Connett JE. Bronchodilator response in the lung health study over 11 yrs. Eur Respir J. 2005 Jul; 26(1):45-51. PMID: 15994388.
      View in: PubMed
    221. Simmons MS, Connett JE, Nides MA, Lindgren PG, Kleerup EC, Murray RP, Bjornson WM, Tashkin D. Smoking reduction and the rate of decline in FEV(1): results from the Lung Health Study. Eur Respir J. 2005 Jun; 25(6):1011-7. PMID: 15929955.
      View in: PubMed
    222. Tashkin D. Smoked marijuana as a cause of lung injury. Monaldi Arch Chest Dis. 2005 Jun; 63(2):93-100. PMID: 16128224.
      View in: PubMed
    223. Sarafian T, Habib N, Mao JT, Tsu IH, Yamamoto ML, Hsu E, Tashkin D, Roth MD. Gene expression changes in human small airway epithelial cells exposed to Delta9-tetrahydrocannabinol. Toxicol Lett. 2005 Aug 14; 158(2):95-107. PMID: 16039398.
      View in: PubMed
    224. Hashibe M, Straif K, Tashkin D, Morgenstern H, Greenland S, Zhang ZF. Epidemiologic review of marijuana use and cancer risk. Alcohol. 2005 Apr; 35(3):265-75. PMID: 16054989.
      View in: PubMed
    225. Cooper CB, Tashkin D. Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease. BMJ. 2005 Mar 19; 330(7492):640-4. PMID: 15774995; PMCID: PMC554913.
    226. Tashkin D. Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease? Curr Opin Pulm Med. 2005 Mar; 11(2):121-8. PMID: 15699783.
      View in: PubMed
    227. Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, Sterz MG, Chung J, FitzGerald JD, Seibold JR, Varga J, Theodore A, Wigley FM, Silver RM, Steen VD, Mayes MD, Connolly MK, Fessler BJ, Rothfield NF, Mubarak K, Molitor J, Tashkin D. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum. 2005 Feb; 52(2):592-600. PMID: 15692967.
      View in: PubMed
    228. Boyd SJ, Tashkin D, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Strategies for quitting among non-treatment-seeking marijuana smokers. Am J Addict. 2005 Jan-Feb; 14(1):35-42. PMID: 15804875.
      View in: PubMed
    229. Anzueto A, Tashkin D, Menjoge S, Kesten S. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. Pulm Pharmacol Ther. 2005; 18(2):75-81. PMID: 15649848.
      View in: PubMed
    230. Tashkin D, Murray HE, Skeans M, Murray RP. Skin manifestations of inhaled corticosteroids in COPD patients: results from Lung Health Study II. Chest. 2004 10; 126(4):1123-33. PMID: 15486373.
      View in: PubMed
    231. Scanlon PD, Connett JE, Wise RA, Tashkin D, Madhok T, Skeans M, Carpenter PC, Bailey WC, Buist AS, Eichenhorn M, Kanner RE, Weinmann G. Loss of bone density with inhaled triamcinolone in Lung Health Study II. Am J Respir Crit Care Med. 2004 Dec 15; 170(12):1302-9. PMID: 15374846.
      View in: PubMed
    232. Clements PJ, Goldin JG, Kleerup EC, Furst DE, Elashoff RM, Tashkin D, Roth MD. Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis. Arthritis Rheum. 2004 Jun; 50(6):1909-17. PMID: 15188367.
      View in: PubMed
    233. Tashkin D. Evidence implicating cocaine as a possible risk factor for HIV infection. J Neuroimmunol. 2004 Feb; 147(1-2):26-7. PMID: 14741422.
      View in: PubMed
    234. Roth MD, Whittaker K, Salehi K, Tashkin D, Baldwin GC. Mechanisms for impaired effector function in alveolar macrophages from marijuana and cocaine smokers. J Neuroimmunol. 2004 Feb; 147(1-2):82-6. PMID: 14741433.
      View in: PubMed
    235. Gardner B, Zhu LX, Roth MD, Tashkin D, Dubinett SM, Sharma S. Cocaine modulates cytokine and enhances tumor growth through sigma receptors. J Neuroimmunol. 2004 Feb; 147(1-2):95-8. PMID: 14741436.
      View in: PubMed
    236. Sarna L, Evangelista L, Tashkin D, Padilla G, Holmes C, Brecht ML, Grannis F. Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer. Chest. 2004 Feb; 125(2):439-45. PMID: 14769722.
      View in: PubMed
    237. Decramer M, Celli B, Tashkin D, Pauwels RA, Burkhart D, Cassino C, Kesten S. Clinical trial design considerations in assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial. COPD. 2004; 1(2):303-12. PMID: 17136995.
      View in: PubMed
    238. Tashkin D, Cooper CB. The role of long-acting bronchodilators in the management of stable COPD. Chest. 2004 Jan; 125(1):249-59. PMID: 14718448.
      View in: PubMed
    239. Zeidler MR, Kleerup EC, Tashkin D. Exhaled nitric oxide in the assessment of asthma. Curr Opin Pulm Med. 2004 Jan; 10(1):31-6. PMID: 14749603.
      View in: PubMed
    240. Mao JT, Tashkin D, Belloni PN, Baileyhealy I, Baratelli F, Roth MD. All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema. Chest. 2003 Nov; 124(5):1724-32. PMID: 14605041.
      View in: PubMed
    241. Gardner B, Zhu LX, Sharma S, Tashkin D, Dubinett SM. Methanandamide increases COX-2 expression and tumor growth in murine lung cancer. FASEB J. 2003 Nov; 17(14):2157-9. PMID: 12958151.
      View in: PubMed
    242. Wise RA, Kanner RE, Lindgren P, Connett JE, Altose MD, Enright PL, Tashkin D. The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD: the Lung Health Study. Chest. 2003 Aug; 124(2):449-58. PMID: 12907528.
      View in: PubMed
    243. Eichenhorn MS, Wise RA, Madhok TC, Gerald LB, Bailey WC, Tashkin D, Scanlon PD. Lack of long-term adverse adrenal effects from inhaled triamcinolone: Lung Health Study II. Chest. 2003 Jul; 124(1):57-62. PMID: 12853502.
      View in: PubMed
    244. Tashkin D, Kesten S. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest. 2003 May; 123(5):1441-9. PMID: 12740259.
      View in: PubMed
    245. Zhu LX, Sharma S, Gardner B, Escuadro B, Atianzar K, Tashkin D, Dubinett SM. IL-10 mediates sigma 1 receptor-dependent suppression of antitumor immunity. J Immunol. 2003 Apr 01; 170(7):3585-91. PMID: 12646621.
      View in: PubMed
    246. Corren J, Tashkin D. Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma. Clin Ther. 2003 Mar; 25(3):776-98. PMID: 12852702.
      View in: PubMed
    247. Shay AH, Choi R, Whittaker K, Salehi K, Kitchen CM, Tashkin D, Roth MD, Baldwin GC. Impairment of antimicrobial activity and nitric oxide production in alveolar macrophages from smokers of marijuana and cocaine. J Infect Dis. 2003 Feb 15; 187(4):700-4. PMID: 12599091.
      View in: PubMed
    248. Berman BA, Wong GC, Bastani R, Hoang T, Jones C, Goldstein DR, Bernert JT, Hammond KS, Tashkin D, Lewis MA. Household smoking behavior and ETS exposure among children with asthma in low-income, minority households. Addict Behav. 2003 Jan-Feb; 28(1):111-28. PMID: 12507531.
      View in: PubMed
    249. Roth MD, Baldwin GC, Tashkin D. Effects of delta-9-tetrahydrocannabinol on human immune function and host defense. Chem Phys Lipids. 2002 Dec 31; 121(1-2):229-39. PMID: 12505703.
      View in: PubMed
    250. Yuan M, Kiertscher SM, Cheng Q, Zoumalan R, Tashkin D, Roth MD. Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J Neuroimmunol. 2002 Dec; 133(1-2):124-31. PMID: 12446015.
      View in: PubMed
    251. Tashkin D, Baldwin GC, Sarafian T, Dubinett S, Roth MD. Respiratory and immunologic consequences of marijuana smoking. J Clin Pharmacol. 2002 Nov; 42(11 Suppl):71S-81S. PMID: 12412839.
      View in: PubMed
    252. Sarafian TA, Kouyoumjian S, Khoshaghideh F, Tashkin D, Roth MD. Delta 9-tetrahydrocannabinol disrupts mitochondrial function and cell energetics. Am J Physiol Lung Cell Mol Physiol. 2003 Feb; 284(2):L298-306. PMID: 12533310.
      View in: PubMed
    253. Kleerup EC, Koyal SN, Marques-Magallanes JA, Goldman MD, Tashkin D. Chronic and acute effects of "crack" cocaine on diffusing capacity, membrane diffusion, and pulmonary capillary blood volume in the lung. Chest. 2002 Aug; 122(2):629-38. PMID: 12171843.
      View in: PubMed
    254. Sarafian TA, Kouyoumjian S, Tashkin D, Roth MD. Synergistic cytotoxicity of Delta(9)-tetrahydrocannabinol and butylated hydroxyanisole. Toxicol Lett. 2002 Jul 21; 133(2-3):171-9. PMID: 12119125.
      View in: PubMed
    255. Tashkin D. The role of small airway inflammation in asthma. Allergy Asthma Proc. 2002 Jul-Aug; 23(4):233-42. PMID: 12221892.
      View in: PubMed
    256. Sarna L, Padilla G, Holmes C, Tashkin D, Brecht ML, Evangelista L. Quality of life of long-term survivors of non-small-cell lung cancer. J Clin Oncol. 2002 Jul 01; 20(13):2920-9. PMID: 12089220.
      View in: PubMed
    257. Baldwin GC, Choi R, Roth MD, Shay AH, Kleerup EC, Simmons MS, Tashkin D. Evidence of chronic damage to the pulmonary microcirculation in habitual users of alkaloidal ("crack") cocaine. Chest. 2002 Apr; 121(4):1231-8. PMID: 11948058.
      View in: PubMed
    258. Mao JT, Goldin JG, Dermand J, Ibrahim G, Brown MS, Emerick A, McNitt-Gray MF, Gjertson DW, Estrada F, Tashkin D, Roth MD. A pilot study of all-trans-retinoic acid for the treatment of human emphysema. Am J Respir Crit Care Med. 2002 Mar 01; 165(5):718-23. PMID: 11874821.
      View in: PubMed
    259. Casasola GG, Alvarez-Sala JL, Marques JA, Sánchez-Alarcos JM, Tashkin D, Espinós D. Cigarette smoking behavior and respiratory alterations during sleep in a healthy population. Sleep Breath. 2002 Mar; 6(1):19-24. PMID: 11917260.
      View in: PubMed
    260. Roth MD, Tashkin D, Choi R, Jamieson BD, Zack JA, Baldwin GC. Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. J Infect Dis. 2002 Mar 01; 185(5):701-5. PMID: 11865430.
      View in: PubMed
    261. Shaw RJ, Djukanovic R, Tashkin D, Millar AB, du Bois RM, Orr PA. The role of small airways in lung disease. Respir Med. 2002 Feb; 96(2):67-80. PMID: 11862964.
      View in: PubMed
    262. Gardner B, Zu LX, Sharma S, Liu Q, Makriyannis A, Tashkin D, Dubinett SM. Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-beta. Biochem Biophys Res Commun. 2002 Jan 11; 290(1):91-6. PMID: 11779138.
      View in: PubMed
    263. Tashkin D. The importance of control in asthma management: do leukotriene receptor antagonists meet patient and physician needs? Allergy Asthma Proc. 2001 Sep-Oct; 22(5):311-9. PMID: 11715222.
      View in: PubMed
    264. Sarafian TA, Tashkin D, Roth MD. Marijuana smoke and Delta(9)-tetrahydrocannabinol promote necrotic cell death but inhibit Fas-mediated apoptosis. Toxicol Appl Pharmacol. 2001 Aug 01; 174(3):264-72. PMID: 11485387.
      View in: PubMed
    265. Chapman KR, Tashkin D, Pye DJ. Gender bias in the diagnosis of COPD. Chest. 2001 Jun; 119(6):1691-5. PMID: 11399692.
      View in: PubMed
    266. Tashkin D, Kanner R, Bailey W, Buist S, Anderson P, Nides M, Gonzales D, Dozier G, Patel MK, Jamerson B. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet. 2001 May 19; 357(9268):1571-5. PMID: 11377644.
      View in: PubMed
    267. McIvor RA, Tashkin D. Underdiagnosis of chronic obstructive pulmonary disease: a rationale for spirometry as a screening tool. Can Respir J. 2001 May-Jun; 8(3):153-8. PMID: 11420591.
      View in: PubMed
    268. Tashkin D. Airway effects of marijuana, cocaine, and other inhaled illicit agents. Curr Opin Pulm Med. 2001 Mar; 7(2):43-61. PMID: 11224724.
      View in: PubMed
    269. Roth MD, Marques-Magallanes JA, Yuan M, Sun W, Tashkin D, Hankinson O. Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and delta (9)-tetrahydrocannabinol. Am J Respir Cell Mol Biol. 2001 Mar; 24(3):339-44. PMID: 11245634.
      View in: PubMed
    270. Zhang ZF, Morgenstern H, Spitz MR, Tashkin D, Yu GP, Hsu TC, Schantz SP. Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1043-9. PMID: 11045786.
      View in: PubMed
    271. Tashkin D. HFA-BDP and its implications for the quiet zone. Respir Med. 2000 Sep; 94 Suppl D:S37-9. PMID: 11003174.
      View in: PubMed
    272. Simmons MS, Nides MA, Rand CS, Wise RA, Tashkin D. Unpredictability of deception in compliance with physician-prescribed bronchodilator inhaler use in a clinical trial. Chest. 2000 Aug; 118(2):290-5. PMID: 10936115.
      View in: PubMed
    273. Zhu LX, Sharma S, Stolina M, Gardner B, Roth MD, Tashkin D, Dubinett SM. Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunol. 2000 Jul 01; 165(1):373-80. PMID: 10861074.
      View in: PubMed
    274. Littner MR, Ilowite JS, Tashkin D, Friedman M, Serby CW, Menjoge SS, Witek TJ. Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000 Apr; 161(4 Pt 1):1136-42. PMID: 10764302.
      View in: PubMed
    275. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS, Tashkin D. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med. 2000 Feb; 161(2 Pt 1):381-90. PMID: 10673175.
      View in: PubMed
    276. Zhang ZF, Morgenstern H, Spitz MR, Tashkin D, Yu GP, Marshall JR, Hsu TC, Schantz SP. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 1999 Dec; 8(12):1071-8. PMID: 10613339.
      View in: PubMed
    277. Goldin JG, Tashkin D, Kleerup EC, Greaser LE, Haywood UM, Sayre JW, Simmons MD, Suttorp M, Colice GL, Vanden Burgt JA, Aberle DR. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. J Allergy Clin Immunol. 1999 Dec; 104(6):S258-67. PMID: 10588987.
      View in: PubMed
    278. Crapo RO, Jensen RL, Hegewald M, Tashkin D. Arterial blood gas reference values for sea level and an altitude of 1,400 meters. Am J Respir Crit Care Med. 1999 Nov; 160(5 Pt 1):1525-31. PMID: 10556115.
      View in: PubMed
    279. Sarafian TA, Magallanes JA, Shau H, Tashkin D, Roth MD. Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids. Am J Respir Cell Mol Biol. 1999 Jun; 20(6):1286-93. PMID: 10340948.
      View in: PubMed
    280. Tashkin D, Nathan RA, Howland WC, Minkwitz MC, Simonson SG, Bonuccelli CM. An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses. J Allergy Clin Immunol. 1999 Feb; 103(2 Pt 1):246-54. PMID: 9949315.
      View in: PubMed
    281. Tashkin D. Extra-fine corticosteroid aerosols from hydrofluoroalkane-134a metered-dose inhalers: potential advantages and disadvantages. Chest. 1999 Feb; 115(2):316-8. PMID: 10027423.
      View in: PubMed
    282. Simmons MS, Nides MA, Kleerup EC, Chapman KR, Milgrom H, Rand CS, Spector SL, Tashkin D. Validation of the Doser, a new device for monitoring metered-dose inhaler use. J Allergy Clin Immunol. 1998 Sep; 102(3):409-13. PMID: 9768581.
      View in: PubMed
    283. Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin D. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst. 1998 Aug 19; 90(16):1198-205. PMID: 9719080.
      View in: PubMed
    284. Goldin JG, McNitt-Gray MF, Sorenson SM, Johnson TD, Dauphinee B, Kleerup EC, Tashkin D, Aberle DR. Airway hyperreactivity: assessment with helical thin-section CT. Radiology. 1998 Aug; 208(2):321-9. PMID: 9680554.
      View in: PubMed
    285. Nelson HS, Bernstein IL, Fink J, Edwards TB, Spector SL, Storms WW, Tashkin D. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group. Chest. 1998 May; 113(5):1264-71. PMID: 9596304.
      View in: PubMed
    286. Baldwin GC, Roth MD, Tashkin D. Acute and chronic effects of cocaine on the immune system and the possible link to AIDS. J Neuroimmunol. 1998 Mar 15; 83(1-2):133-8. PMID: 9610681.
      View in: PubMed
    287. Wise RA, Enright PL, Connett JE, Anthonisen NR, Kanner RE, Lindgren P, O'Hara P, Owens GR, Rand CS, Tashkin D. Effect of weight gain on pulmonary function after smoking cessation in the Lung Health Study. Am J Respir Crit Care Med. 1998 Mar; 157(3 Pt 1):866-72. PMID: 9517604.
      View in: PubMed
    288. Roth MD, Arora A, Barsky SH, Kleerup EC, Simmons M, Tashkin D. Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med. 1998 Mar; 157(3 Pt 1):928-37. PMID: 9517614.
      View in: PubMed
    289. Tashkin D. New devices for asthma. J Allergy Clin Immunol. 1998 Feb; 101(2 Pt 2):S409-16. PMID: 9500741.
      View in: PubMed
    290. Gross N, Tashkin D, Miller R, Oren J, Coleman W, Linberg S. Inhalation by nebulization of albuterol-ipratropium combination (Dey combination) is superior to either agent alone in the treatment of chronic obstructive pulmonary disease. Dey Combination Solution Study Group. Respiration. 1998; 65(5):354-62. PMID: 9782217.
      View in: PubMed
    291. Matthias P, Tashkin D, Marques-Magallanes JA, Wilkins JN, Simmons MS. Effects of varying marijuana potency on deposition of tar and delta9-THC in the lung during smoking. Pharmacol Biochem Behav. 1997 Dec; 58(4):1145-50. PMID: 9408226.
      View in: PubMed
    292. McNitt-Gray MF, Goldin JG, Johnson TD, Tashkin D, Aberle DR. Development and testing of image-processing methods for the quantitative assessment of airway hyperresponsiveness from high-resolution CT images. J Comput Assist Tomogr. 1997 Nov-Dec; 21(6):939-47. PMID: 9386287.
      View in: PubMed
    293. Baldwin GC, Tashkin D, Buckley DM, Park AN, Dubinett SM, Roth MD. Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am J Respir Crit Care Med. 1997 Nov; 156(5):1606-13. PMID: 9372683.
      View in: PubMed
    294. Mao JT, Zhu LX, Sharma S, Chen K, Huang M, Santiago SJ, Gulsurd J, Tashkin D, Dubinett SM. Cocaine inhibits human endothelial cell IL-8 production: the role of transforming growth factor-beta. Cell Immunol. 1997 Oct 10; 181(1):38-43. PMID: 9344494.
      View in: PubMed
    295. Marques-Magallanes JA, Koyal SN, Cooper CB, Kleerup EC, Tashkin D. Impact of habitual cocaine smoking on the physiologic response to maximum exercise. Chest. 1997 Oct; 112(4):1008-16. PMID: 9377910.
      View in: PubMed
    296. Fligiel SE, Roth MD, Kleerup EC, Barsky SH, Simmons MS, Tashkin D. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest. 1997 Aug; 112(2):319-26. PMID: 9266864.
      View in: PubMed
    297. Tashkin D, Kleerup EC, Hoh CK, Kim KJ, Webber MM, Gil E. Effects of 'crack' cocaine on pulmonary alveolar permeability. Chest. 1997 Aug; 112(2):327-35. PMID: 9266865.
      View in: PubMed
    298. Tashkin D, Roth MD, Dubinett SM. Medicinal marijuana? N Engl J Med. 1997 Apr 17; 336(16):1186; author reply 1186-7. PMID: 9102572.
      View in: PubMed
    299. Pearlman DS, Noonan MJ, Tashkin D, Goldstein MF, Hamedani AG, Kellerman DJ, Schaberg A. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma. Ann Allergy Asthma Immunol. 1997 Apr; 78(4):356-62. PMID: 9109702.
      View in: PubMed
    300. Baldwin GC, Buckley DM, Roth MD, Kleerup EC, Tashkin D. Acute activation of circulating polymorphonuclear neutrophils following in vivo administration of cocaine. A potential etiology for pulmonary injury. Chest. 1997 Mar; 111(3):698-705. PMID: 9118711.
      View in: PubMed
    301. Wallace JM, Stone GS, Browdy BL, Tashkin D, Hopewell PC, Glassroth J, Rosen MJ, Reichman LB, Kvale PA. Nonspecific airway hyperresponsiveness in HIV disease. Pulmonary Complications of HIV Infection Study Group. Chest. 1997 Jan; 111(1):121-7. PMID: 8996005.
      View in: PubMed
    302. Gorelick DA, Simmons MS, Carriero N, Tashkin D. Characteristics of smoked drug use among cocaine smokers. Am J Addict. 1997; 6(3):237-45. PMID: 9256990.
      View in: PubMed
    303. Tashkin D, Simmons MS, Sherrill DL, Coulson AH. Heavy habitual marijuana smoking does not cause an accelerated decline in FEV1 with age. Am J Respir Crit Care Med. 1997 Jan; 155(1):141-8. PMID: 9001303.
      View in: PubMed
    304. Kleerup EC, Wong M, Marques-Magallanes JA, Goldman MD, Tashkin D. Acute effects of intravenous cocaine on pulmonary artery pressure and cardiac index in habitual crack smokers. Chest. 1997 Jan; 111(1):30-5. PMID: 8995989.
      View in: PubMed
    305. Tashkin D, Kleerup EC, Koyal SN, Marques JA, Goldman MD. Acute effects of inhaled and i.v. cocaine on airway dynamics. Chest. 1996 Oct; 110(4):904-10. PMID: 8874243.
      View in: PubMed
    306. Mao JT, Huang M, Wang J, Sharma S, Tashkin D, Dubinett SM. Cocaine down-regulates IL-2-induced peripheral blood lymphocyte IL-8 and IFN-gamma production. Cell Immunol. 1996 Sep 15; 172(2):217-23. PMID: 8964083.
      View in: PubMed
    307. Tashkin D, Altose MD, Connett JE, Kanner RE, Lee WW, Wise RA. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. Am J Respir Crit Care Med. 1996 Jun; 153(6 Pt 1):1802-11. PMID: 8665038.
      View in: PubMed
    308. Simmons MS, Nides MA, Rand CS, Wise RA, Tashkin D. Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial. Chest. 1996 Apr; 109(4):963-8. PMID: 8635378.
      View in: PubMed
    309. Kleerup EC, Tashkin D, Cline AC, Ekholm BP. Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma. Chest. 1996 Mar; 109(3):702-7. PMID: 8617079.
      View in: PubMed
    310. Gelb AF, Hogg JC, Müller NL, Schein MJ, Kuei J, Tashkin D, Epstein JD, Kollin J, Green RH, Zamel N, Elliott WM, Hadjiaghai L. Contribution of emphysema and small airways in COPD. Chest. 1996 Feb; 109(2):353-9. PMID: 8620705.
      View in: PubMed
    311. Tashkin D, Bleecker E, Braun S, Campbell S, DeGraff AC, Hudgel DW, Boyars MC, Sahn S. Results of a multicenter study of nebulized inhalant bronchodilator solutions. Am J Med. 1996 Jan 29; 100(1A):62S-69. PMID: 8610720.
      View in: PubMed
    312. Tashkin D. What is the true impact of crack on the lung? Chest. 1995 Oct; 108(4):1180-1. PMID: 7555144.
      View in: PubMed
    313. Kleerup EC, Tashkin D. Outpatient treatment of adult asthma. West J Med. 1995 Jul; 163(1):49-63. PMID: 7667983; PMCID: PMC1302916.
    314. Tashkin D. Multiple dose regimens. Impact on compliance. Chest. 1995 May; 107(5 Suppl):176S-182S. PMID: 7743823.
      View in: PubMed
    315. Sidney S, Tekawa IS, Friedman GD, Sadler MC, Tashkin D. Mentholated cigarette use and lung cancer. Arch Intern Med. 1995 Apr 10; 155(7):727-32. PMID: 7695461.
      View in: PubMed
    316. Nides MA, Rakos RF, Gonzales D, Murray RP, Tashkin D, Bjornson-Benson WM, Lindgren P, Connett JE. Predictors of initial smoking cessation and relapse through the first 2 years of the Lung Health Study. J Consult Clin Psychol. 1995 Feb; 63(1):60-9. PMID: 7896992.
      View in: PubMed
    317. Sherman MP, Aeberhard EE, Wong VZ, Simmons MS, Roth MD, Tashkin D. Effects of smoking marijuana, tobacco or cocaine alone or in combination on DNA damage in human alveolar macrophages. Life Sci. 1995; 56(23-24):2201-7. PMID: 7776850.
      View in: PubMed
    318. Gil E, Chen B, Kleerup E, Webber M, Tashkin D. Acute and chronic effects of marijuana smoking on pulmonary alveolar permeability. Life Sci. 1995; 56(23-24):2193-9. PMID: 7776849.
      View in: PubMed
    319. Simmons MS, Tashkin D. The relationship of tobacco and marijuana smoking characteristics. Life Sci. 1995; 56(23-24):2185-91. PMID: 7776848.
      View in: PubMed
    320. Johnson LR, Enright PL, Voelker HT, Tashkin D. Volume spirometers need automated internal temperature sensors. Am J Respir Crit Care Med. 1994 Dec; 150(6 Pt 1):1575-80. PMID: 7952617.
      View in: PubMed
    321. Kanner RE, Connett JE, Altose MD, Buist AS, Lee WW, Tashkin D, Wise RA. Gender difference in airway hyperresponsiveness in smokers with mild COPD. The Lung Health Study. Am J Respir Crit Care Med. 1994 Oct; 150(4):956-61. PMID: 7921469.
      View in: PubMed
    322. Fink JN, Forman S, Silvers WS, Soifer MM, Tashkin D, Wilson AF. A double-blind study of the efficacy of nedocromil sodium in the management of asthma in patients using high doses of bronchodilators. J Allergy Clin Immunol. 1994 Sep; 94(3 Pt 1):473-81. PMID: 8083452.
      View in: PubMed
    323. Jarvik ME, Tashkin D, Caskey NH, McCarthy WJ, Rosenblatt MR. Mentholated cigarettes decrease puff volume of smoke and increase carbon monoxide absorption. Physiol Behav. 1994 Sep; 56(3):563-70. PMID: 7972409.
      View in: PubMed
    324. Alazard M, Siegel SC, Tashkin D. Macronodular pulmonary infiltrates in a patient with chronic asthma and productive cough. Ann Allergy. 1994 Jun; 72(6):491-7. PMID: 8203793.
      View in: PubMed
    325. Tashkin D, Detels R, Simmons M, Liu H, Coulson AH, Sayre J, Rokaw S. The UCLA population studies of chronic obstructive respiratory disease: XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second. Am J Respir Crit Care Med. 1994 May; 149(5):1209-17. PMID: 8173761.
      View in: PubMed
    326. Wallace JM, Oishi JS, Barbers RG, Simmons MS, Tashkin D. Lymphocytic subpopulation profiles in bronchoalveolar lavage fluid and peripheral blood from tobacco and marijuana smokers. Chest. 1994 Mar; 105(3):847-52. PMID: 7907538.
      View in: PubMed
    327. Tashkin D, Clements PJ, Wright RS, Gong H, Simmons MS, Lachenbruch PA, Furst DE. Interrelationships between pulmonary and extrapulmonary involvement in systemic sclerosis. A longitudinal analysis. Chest. 1994 Feb; 105(2):489-95. PMID: 8306752.
      View in: PubMed
    328. Nides MA, Tashkin D, Simmons MS, Wise RA, Li VC, Rand CS. Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest. 1993 Aug; 104(2):501-7. PMID: 8339641.
      View in: PubMed
    329. Gelb AF, Schein M, Kuei J, Tashkin D, Müller NL, Hogg JC, Epstein JD, Zamel N. Limited contribution of emphysema in advanced chronic obstructive pulmonary disease. Am Rev Respir Dis. 1993 May; 147(5):1157-61. PMID: 8484625.
      View in: PubMed
    330. Behm FM, Schur C, Levin ED, Tashkin D, Rose JE. Clinical evaluation of a citric acid inhaler for smoking cessation. Drug Alcohol Depend. 1993 Jan; 31(2):131-8. PMID: 8436059.
      View in: PubMed
    331. Tashkin D, Simmons MS, Chang P, Liu H, Coulson AH. Effects of smoked substance abuse on nonspecific airway hyperresponsiveness. Am Rev Respir Dis. 1993 Jan; 147(1):97-103. PMID: 8420440.
      View in: PubMed
    332. Rand CS, Wise RA, Nides M, Simmons MS, Bleecker ER, Kusek JW, Li VC, Tashkin D. Metered-dose inhaler adherence in a clinical trial. Am Rev Respir Dis. 1992 Dec; 146(6):1559-64. PMID: 1456575.
      View in: PubMed
    333. Gelb AF, Zamel N, Colchen A, Tashkin D, Maurer JR, Patterson GA, Epstein JD. Physiologic studies of tracheobronchial stents in airway obstruction. Am Rev Respir Dis. 1992 Oct; 146(4):1088-90. PMID: 1416400.
      View in: PubMed
    334. Wu HD, Wright RS, Sassoon CS, Tashkin D. Effects of smoked marijuana of varying potency on ventilatory drive and metabolic rate. Am Rev Respir Dis. 1992 Sep; 146(3):716-21. PMID: 1325750.
      View in: PubMed
    335. Mazza JA, Tashkin D, Reed CE. Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma. Ann Allergy. 1992 Mar; 68(3):267-73. PMID: 1532117.
      View in: PubMed
    336. Tashkin D, Altose MD, Bleecker ER, Connett JE, Kanner RE, Lee WW, Wise R. The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group. Am Rev Respir Dis. 1992 Feb; 145(2 Pt 1):301-10. PMID: 1736734.
      View in: PubMed
    337. Tashkin D, Khalsa ME, Gorelick D, Chang P, Simmons MS, Coulson AH, Gong H. Pulmonary status of habitual cocaine smokers. Am Rev Respir Dis. 1992 Jan; 145(1):92-100. PMID: 1731605.
      View in: PubMed
    338. Tashkin D, Gorelick D, Khalsa ME, Simmons M, Chang P. Respiratory effects of cocaine freebasing among habitual cocaine users. J Addict Dis. 1992; 11(4):59-70. PMID: 1486094.
      View in: PubMed
    339. Sherman MP, Campbell LA, Gong H, Roth MD, Tashkin D. Antimicrobial and respiratory burst characteristics of pulmonary alveolar macrophages recovered from smokers of marijuana alone, smokers of tobacco alone, smokers of marijuana and tobacco, and nonsmokers. Am Rev Respir Dis. 1991 Dec; 144(6):1351-6. PMID: 1660230.
      View in: PubMed
    340. Tashkin D, Gliederer F, Rose J, Change P, Hui KK, Yu JL, Wu TC. Effects of varying marijuana smoking profile on deposition of tar and absorption of CO and delta-9-THC. Pharmacol Biochem Behav. 1991 Nov; 40(3):651-6. PMID: 1666923.
      View in: PubMed
    341. Tashkin D, Gliederer F, Rose J, Chang P, Hui KK, Yu JL, Wu TC. Tar, CO and delta 9THC delivery from the 1st and 2nd halves of a marijuana cigarette. Pharmacol Biochem Behav. 1991 Nov; 40(3):657-61. PMID: 1666924.
      View in: PubMed
    342. Sherman MP, Roth MD, Gong H, Tashkin D. Marijuana smoking, pulmonary function, and lung macrophage oxidant release. Pharmacol Biochem Behav. 1991 Nov; 40(3):663-9. PMID: 1666925.
      View in: PubMed
    343. Sherman MP, Loro ML, Wong VZ, Tashkin D. Cytokine- and Pneumocystis carinii- induced L-arginine oxidation by murine and human pulmonary alveolar macrophages. J Protozool. 1991 Nov-Dec; 38(6):234S-236S. PMID: 1818184.
      View in: PubMed
    344. Fligiel SE, Beals TF, Tashkin D, Paule MG, Scallet AC, Ali SF, Bailey JR, Slikker W. Marijuana exposure and pulmonary alterations in primates. Pharmacol Biochem Behav. 1991 Nov; 40(3):637-42. PMID: 1806951.
      View in: PubMed
    345. Tashkin D, Rand C, Nides M, Simmons M, Wise R, Coulson AH, Li V, Gong H. A nebulizer chronolog to monitor compliance with inhaler use. Am J Med. 1991 Oct 21; 91(4A):33S-36S. PMID: 1951401.
      View in: PubMed
    346. Bourque LB, Tashkin D, Clark VA, Schuler R. Demographic and health characteristics of heavy marijuana smokers in Los Angeles County. Int J Addict. 1991 Jul; 26(7):739-55. PMID: 1959998.
      View in: PubMed
    347. Hourani JM, Bellamy PE, Tashkin D, Batra P, Simmons MS. Pulmonary dysfunction in advanced liver disease: frequent occurrence of an abnormal diffusing capacity. Am J Med. 1991 Jun; 90(6):693-700. PMID: 1904192.
      View in: PubMed
    348. Barbers RG, Evans MJ, Gong H, Tashkin D. Enhanced alveolar monocytic phagocyte (macrophage) proliferation in tobacco and marijuana smokers. Am Rev Respir Dis. 1991 May; 143(5 Pt 1):1092-5. PMID: 2024820.
      View in: PubMed
    349. Detels R, Tashkin D, Sayre JW, Rokaw SN, Massey FJ, Coulson AH, Wegman DH. The UCLA population studies of CORD: X. A cohort study of changes in respiratory function associated with chronic exposure to SOx, NOx, and hydrocarbons. Am J Public Health. 1991 Mar; 81(3):350-9. PMID: 1994744; PMCID: PMC1405012.
    350. Gelb AF, Aberle DR, Schein MJ, Naidich DP, Epstein JD, Tashkin D. Computed tomography and bronchoscopy in chest radiographically occult main-stem neoplasm diagnosis and Nd-YAG laser treatment in 8 patients. West J Med. 1990 Oct; 153(4):385-9. PMID: 2244372; PMCID: PMC1002566.
    351. Wright RS, Levine MS, Bellamy PE, Simmons MS, Batra P, Stevenson LW, Walden JA, Laks H, Tashkin D. Ventilatory and diffusion abnormalities in potential heart transplant recipients. Chest. 1990 Oct; 98(4):816-20. PMID: 2209136.
      View in: PubMed
    352. Aberle DR, Hansell DM, Brown K, Tashkin D. Lymphangiomyomatosis: CT, chest radiographic, and functional correlations. Radiology. 1990 Aug; 176(2):381-7. PMID: 2367651.
      View in: PubMed
    353. Tashkin D. Pulmonary complications of smoked substance abuse. West J Med. 1990 May; 152(5):525-30. PMID: 2190420; PMCID: PMC1002405.
    354. Gong H, Tashkin D, Dauphinee B, Djahed B, Wu TC. Effects of oral cetirizine, a selective H1 antagonist, on allergen- and exercise-induced bronchoconstriction in subjects with asthma. J Allergy Clin Immunol. 1990 Mar; 85(3):632-41. PMID: 1968919.
      View in: PubMed
    355. Tinkelman DG, Brandon ML, Grieco M, Hudson L, Rosenthal RR, Spector SL, Tashkin D, Votteri B. Comparison of safety and efficacy of inhaled pirbuterol with metaproterenol. Ann Allergy. 1990 Feb; 64(2 Pt 2):202-6. PMID: 2405746.
      View in: PubMed
    356. Tashkin D, Fligiel S, Wu TC, Gong H, Barbers RG, Coulson AH, Simmons MS, Beals TF. Effects of habitual use of marijuana and/or cocaine on the lung. NIDA Res Monogr. 1990; 99:63-87. PMID: 2267014.
      View in: PubMed
    357. Hathaway EH, Tashkin D, Simmons MS. Intraindividual variability in serial measurements of DLCO and alveolar volume over one year in eight healthy subjects using three independent measuring systems. Am Rev Respir Dis. 1989 Dec; 140(6):1818-22. PMID: 2604306.
      View in: PubMed
    358. Kuei JH, Tashkin D, Figlin RA. Pulmonary toxicity of recombinant human tumor necrosis factor. Chest. 1989 Aug; 96(2):334-8. PMID: 2752816.
      View in: PubMed
    359. van Vunakis H, Tashkin D, Rigas B, Simmons M, Gjika HB, Clark VA. Relative sensitivity and specificity of salivary and serum cotinine in identifying tobacco-smoking status of self-reported nonsmokers and smokers of tobacco and/or marijuana. Arch Environ Health. 1989 Jan-Feb; 44(1):53-8. PMID: 2644896.
      View in: PubMed
    360. Gelb AF, Tashkin D, Epstein JD, Szeftel A, Fairshter R. Physiologic characteristics of malignant unilateral main-stem bronchial obstruction. Diagnosis and Nd-YAG laser treatment. Am Rev Respir Dis. 1988 Dec; 138(6):1382-5. PMID: 2462389.
      View in: PubMed
    361. Gelb AF, Tashkin D, Epstein JD, Fairshter R, Zamel N. Diagnosis and Nd-YAG laser treatment of unsuspected malignant tracheal obstruction. Chest. 1988 Oct; 94(4):767-71. PMID: 2458888.
      View in: PubMed
    362. Van Vunakis H, Tashkin D, Simmons M, Clark VA. Decreased serum cotinine levels in smokers of both tobacco and marijuana as compared with smokers of tobacco only. Pharmacol Biochem Behav. 1988 Aug; 30(4):895-8. PMID: 3227038.
      View in: PubMed
    363. Gong H, Simmons MS, Clark VA, Tashkin D. Metered-dose inhaler usage in subjects with asthma: comparison of Nebulizer Chronolog and daily diary recordings. J Allergy Clin Immunol. 1988 Jul; 82(1):5-10. PMID: 3392369.
      View in: PubMed
    364. Harber P, Tashkin D, Shimozaki S, Hathaway E. Veracity of disability claimants' self-reports of current smoking status. Comparison of carboxyhemoglobin levels from disability claimant and reference population. Chest. 1988 Mar; 93(3):561-4. PMID: 3342666.
      View in: PubMed
    365. Wu TC, Tashkin D, Djahed B, Rose JE. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med. 1988 Feb 11; 318(6):347-51. PMID: 3340105.
      View in: PubMed
    366. Fligiel SE, Venkat H, Gong H, Tashkin D. Bronchial pathology in chronic marijuana smokers: a light and electron microscopic study. J Psychoactive Drugs. 1988 Jan-Mar; 20(1):33-42. PMID: 3392631.
      View in: PubMed
    367. Wallace JM, Tashkin D, Oishi JS, Barbers RG. Peripheral blood lymphocyte subpopulations and mitogen responsiveness in tobacco and marijuana smokers. J Psychoactive Drugs. 1988 Jan-Mar; 20(1):9-14. PMID: 3392635.
      View in: PubMed
    368. Gong H, Tashkin D, Valentine JL, Simmons MS, Clark VA, Coulson AH. Sensitivity and specificity of serum delta 9-tetrahydrocannabinol and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol by radioimmunoassay in identifying habitual daily smokers of marijuana. J Psychoactive Drugs. 1988 Jan-Mar; 20(1):103-6. PMID: 2839653.
      View in: PubMed
    369. Wu TC, Tashkin D, Rose JE, Djahed B. Influence of marijuana potency and amount of cigarette consumed on marijuana smoking pattern. J Psychoactive Drugs. 1988 Jan-Mar; 20(1):43-6. PMID: 2839655.
      View in: PubMed
    370. Barbers RG, Oishi J, Gong H, Tashkin D, Wallace JM, Baker SS. Chemotaxis of peripheral blood and lung leukocytes obtained from tobacco and marijuana smokers. J Psychoactive Drugs. 1988 Jan-Mar; 20(1):15-20. PMID: 3392628.
      View in: PubMed
    371. Tashkin D, Simmons M, Clark V. Effect of habitual smoking of marijuana alone and with tobacco on nonspecific airways hyperreactivity. J Psychoactive Drugs. 1988 Jan-Mar; 20(1):21-5. PMID: 3392629.
      View in: PubMed
    372. Tashkin D, Wu TC, Djahed B. Acute and chronic effects of marijuana smoking compared with tobacco smoking on blood carboxyhemoglobin levels. J Psychoactive Drugs. 1988 Jan-Mar; 20(1):27-31. PMID: 3392630.
      View in: PubMed
    373. Okrent DG, Tessler S, Twersky RA, Tashkin D. Metabolic acidosis not due to lactic acidosis in patients with severe acute asthma. Crit Care Med. 1987 Dec; 15(12):1098-101. PMID: 3677762.
      View in: PubMed
    374. Harber P, Lew M, Tashkin D, Simmons M. Factor analysis of clinical data from asbestos workers: implications for diagnosis and screening. Br J Ind Med. 1987 Nov; 44(11):780-4. PMID: 3689710; PMCID: PMC1007918.
    375. Detels R, Tashkin D, Sayre JW, Rokaw SN, Coulson AH, Massey FJ, Wegman DH. The UCLA population studies of chronic obstructive respiratory disease. 9. Lung function changes associated with chronic exposure to photochemical oxidants; a cohort study among never-smokers. Chest. 1987 Oct; 92(4):594-603. PMID: 3652745.
      View in: PubMed
    376. Tashkin D, Simmons MS, Coulson AH, Clark VA, Gong H. Respiratory effects of cocaine "freebasing" among habitual users of marijuana with or without tobacco. Chest. 1987 Oct; 92(4):638-44. PMID: 3652749.
      View in: PubMed
    377. Harber P, Tashkin D, Lew M, Simmons M. Physiologic categorization of asbestos-exposed workers. Chest. 1987 Sep; 92(3):494-9. PMID: 3622026.
      View in: PubMed
    378. Tashkin D. Internal medicine: use of ipratropium bromide in chronic obstructive pulmonary disease. West J Med. 1987 Sep; 147(3):321. PMID: 18750309.
      View in: PubMed
    379. Gong H, Fligiel S, Tashkin D, Barbers RG. Tracheobronchial changes in habitual, heavy smokers of marijuana with and without tobacco. Am Rev Respir Dis. 1987 Jul; 136(1):142-9. PMID: 3496818.
      View in: PubMed
    380. Greenwald GI, Tashkin D, Gong H, Simmons M, Duann S, Furst DE, Clements P. Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis. Prospective study. Am J Med. 1987 Jul; 83(1):83-92. PMID: 3300327.
      View in: PubMed
    381. Brik A, Tashkin D, Gong H, Dauphinee B, Lee E. Effect of cetirizine, a new histamine H1 antagonist, on airway dynamics and responsiveness to inhaled histamine in mild asthma. J Allergy Clin Immunol. 1987 Jul; 80(1):51-6. PMID: 2885355.
      View in: PubMed
    382. Barbers RG, Gong H, Tashkin D, Oishi J, Wallace JM. Differential examination of bronchoalveolar lavage cells in tobacco cigarette and marijuana smokers. Am Rev Respir Dis. 1987 Jun; 135(6):1271-5. PMID: 3592403.
      View in: PubMed
    383. Gelb AF, Tashkin D, Epstein JD, Zamel N. Nd-YAG laser surgery for severe tracheal stenosis physiologically and clinically masked by severe diffuse obstructive pulmonary disease. Chest. 1987 Feb; 91(2):166-70. PMID: 3802927.
      View in: PubMed
    384. Tashkin D, Coulson AH, Clark VA, Simmons M, Bourque LB, Duann S, Spivey GH, Gong H. Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis. 1987 Jan; 135(1):209-16. PMID: 3492159.
      View in: PubMed
    385. Tashkin D, Ashutosh K, Bleecker ER, Britt EJ, Cugell DW, Cummiskey JM, DeLorenzo L, Gilman MJ, Gross GN, Gross NJ. Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study. Am J Med. 1986 Nov 14; 81(5A):81-90. PMID: 2947465.
      View in: PubMed
    386. Gong H, Bradley PW, Simmons MS, Tashkin D. Impaired exercise performance and pulmonary function in elite cyclists during low-level ozone exposure in a hot environment. Am Rev Respir Dis. 1986 Oct; 134(4):726-33. PMID: 3767129.
      View in: PubMed
    387. Gong H, Simmons MS, Tashkin D, Hui KK, Lee EY. Bronchodilator effects of caffeine in coffee. A dose-response study of asthmatic subjects. Chest. 1986 Mar; 89(3):335-42. PMID: 3948545.
      View in: PubMed
    388. Tashkin D, Kroening RJ, Bresler DE, Simmons M, Coulson AH, Kerschnar H. A controlled trial of real and simulated acupuncture in the management of chronic asthma. J Allergy Clin Immunol. 1985 Dec; 76(6):855-64. PMID: 3905922.
      View in: PubMed
    389. Soffer M, Tashkin D, Shapiro BJ, Littner M, Harvey E, Farr S. Conservation of oxygen supply using a reservoir nasal cannula in hypoxemic patients at rest and during exercise. Chest. 1985 Nov; 88(5):663-8. PMID: 3931988.
      View in: PubMed
    390. Harber P, SooHoo K, Tashkin D. Is the MVV:FEV1 ratio useful for assessing spirometry validity? Chest. 1985 Jul; 88(1):52-7. PMID: 4006556.
      View in: PubMed
    391. Gelb AF, Tashkin D, Epstein JD, Gong H, Zamel N. Exercise-induced bronchodilation in asthma. Chest. 1985 Feb; 87(2):196-201. PMID: 3967526.
      View in: PubMed
    392. Gong H, Tashkin D, Lee EY, Simmons MS. Hypoxia-altitude simulation test. Evaluation of patients with chronic airway obstruction. Am Rev Respir Dis. 1984 Dec; 130(6):980-6. PMID: 6508019.
      View in: PubMed
    393. Sassoon CS, McAlpine SW, Tashkin D, Baydur A, Quismorio FP, Mongan ES. Small airways function in nonsmokers with rheumatoid arthritis. Arthritis Rheum. 1984 Nov; 27(11):1218-26. PMID: 6497918.
      View in: PubMed
    394. Tashkin D, Clark VA, Coulson AH, Simmons M, Bourque LB, Reems C, Detels R, Sayre JW, Rokaw SN. The UCLA population studies of chronic obstructive respiratory disease. VIII. Effects of smoking cessation on lung function: a prospective study of a free-living population. Am Rev Respir Dis. 1984 Nov; 130(5):707-15. PMID: 6497153.
      View in: PubMed
    395. Tashkin D, Clark VA, Simmons M, Reems C, Coulson AH, Bourque LB, Sayre JW, Detels R, Rokaw S. The UCLA population studies of chronic obstructive respiratory disease. VII. Relationship between parental smoking and children's lung function. Am Rev Respir Dis. 1984 Jun; 129(6):891-7. PMID: 6732049.
      View in: PubMed
    396. Detels R, Sayre JW, Tashkin D, Massey FJ, Coulson AH, Rokaw SN. The UCLA population studies of chronic obstructive respiratory disease. VI. Relationship of physiologic factors to rate of change in forced expiratory volume in one second and forced vital capacity. Am Rev Respir Dis. 1984 Apr; 129(4):533-7. PMID: 6711996.
      View in: PubMed
    397. Gong H, Tashkin D, Simmons MS, Calvarese B, Shapiro BJ. Acute and subacute bronchial effects of oral cannabinoids. Clin Pharmacol Ther. 1984 Jan; 35(1):26-32. PMID: 6690168.
      View in: PubMed
    398. Tashkin D, Clark VA, Coulson AH, Bourque LB, Simmons M, Reems C, Detels R, Rokaw S. Comparison of lung function in young nonsmokers and smokers before and after initiation of the smoking habit. A prospective study. Am Rev Respir Dis. 1983 Jul; 128(1):12-6. PMID: 6870055.
      View in: PubMed
    399. Ungerer RG, Tashkin D, Furst D, Clements PJ, Gong H, Bein M, Smith JW, Roberts N, Cabeen W. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med. 1983 Jul; 75(1):65-74. PMID: 6859087.
      View in: PubMed
    400. Littner MR, Tashkin D, Siegel SC, Katz R. Double-blind comparison of acute effects of inhaled albuterol, isoproterenol and placebo on cardiopulmonary function and gas exchange in asthmatic children. Ann Allergy. 1983 May; 50(5):309-16. PMID: 6846920.
      View in: PubMed
    401. Gong H, Tashkin D, Calvarese B. Comparison of bronchial effects of nabilone and terbutaline in healthy and asthmatic subjects. J Clin Pharmacol. 1983 Apr; 23(4):127-33. PMID: 6306060.
      View in: PubMed
    402. Tashkin D, Coulson AH, Simmons MS, Spivey GH. Respiratory symptoms of flight attendants during high-altitude flight: possible relation to cabin ozone exposure. Int Arch Occup Environ Health. 1983; 52(2):117-37. PMID: 6629504.
      View in: PubMed
    403. Conolly ME, Tashkin D, Hui KK, Littner MR, Wolfe RN. Selective subsensitization of beta-adrenergic receptors in central airways of asthmatics and normal subjects during long-term therapy with inhaled salbutamol. J Allergy Clin Immunol. 1982 Dec; 70(6):423-31. PMID: 6292279.
      View in: PubMed
    404. Detels R, Tashkin D, Simmons MS, Carmichael HE, Sayre JW, Rokaw SN, Coulson AH. The UCLA population studies of chronic obstructive respiratory disease. 5. Agreement and disagreement of tests in identifying abnormal lung function. Chest. 1982 Nov; 82(5):630-8. PMID: 7128229.
      View in: PubMed
    405. Scarpace PJ, Littner MR, Tashkin D, Abrass IB. Lymphocyte beta-adrenergic refractoriness induced by theophylline or metaproterenol in healthy and asthmatic subjects. Life Sci. 1982 Oct 11; 31(15):1567-73. PMID: 6292641.
      View in: PubMed
    406. Gelb AF, Tashkin D, Zamel N. Emphysema, airflow limitation and small airways dysfunction. Chest. 1982 Jul; 82(1):4-5. PMID: 7083934.
      View in: PubMed
    407. Tashkin D, Ungerer R, Wolfe R, Mendoza G, Calvarese B. Effect of orally administered cimetidine on histamine- and antigen-induced bronchospasm in subjects with asthma. Am Rev Respir Dis. 1982 Jun; 125(6):691-5. PMID: 7091876.
      View in: PubMed
    408. Mohsenifar Z, Tashkin D, Carson SA, Bellamy PE. Pulmonary function in patients with relapsing polychondritis. Chest. 1982 Jun; 81(6):711-7. PMID: 7075306.
      View in: PubMed
    409. Tashkin D, Conolly ME, Deutsch RI, Hui KK, Littner M, Scarpace P, Abrass I. Subsensitization of beta-adrenoceptors in airways and lymphocytes of healthy and asthmatic subjects. Am Rev Respir Dis. 1982 Feb; 125(2):185-93. PMID: 6278998.
      View in: PubMed
    410. Wolfe RN, Hui KK, Conolly ME, Tashkin D, Fisher HK. A study of beta-adrenergic and prostaglandin receptors in patients with aspirin-induced bronchospasm. J Allergy Clin Immunol. 1982 Jan; 69(1 Pt 1):46-50. PMID: 6274937.
      View in: PubMed
    411. Littner MR, Tashkin D, Calvarese B, Bautista M. Acute bronchial and cardiovascular effects of increasing doses of pirbuterol acetate aerosol in asthma. Ann Allergy. 1982 Jan; 48(1):14-20. PMID: 7055342.
      View in: PubMed
    412. Detels R, Sayre JW, Coulson AH, Rokaw SN, Massey FJ, Tashkin D, Wu MM. The UCLA population studies of chronic obstructive respiratory disease. IV. Respiratory effect of long-term exposure to photochemical oxidants, nitrogen dioxide, and sulfates on current and never smokers. Am Rev Respir Dis. 1981 Dec; 124(6):673-80. PMID: 7316271.
      View in: PubMed
    413. Ungerer RG, Tashkin D, Siegel SC, Deutsch RI. Effect of inhaled iodoxamide tromethamine in prevention of antigen-induced bronchospasm. J Allergy Clin Immunol. 1981 Dec; 68(6):471-8. PMID: 7310012.
      View in: PubMed
    414. Gong H, Tashkin D, Calvarese BM. Alcohol-induced bronchospasm in an asthmatic patient: pharmacologic evaluation of the mechanism. Chest. 1981 Aug; 80(2):167-73. PMID: 7249761.
      View in: PubMed
    415. Detels R, Sayre JW, Coulson AH, Rokaw SN, Massey FJ, Tashkin D, Wu MM. Respiratory effect of longterm exposure to two mixes of air pollutants in Los Angeles County. Chest. 1981 Jul; 80(1 Suppl):27-9. PMID: 7249729.
      View in: PubMed
    416. Clements PJ, Furst DE, Cabeen W, Tashkin D, Paulus HE, Roberts N. The relationship arrhythmias and conduction disturbances to other manifestations of cardiopulmonary disease in progressive systemic sclerosis (PSS). Am J Med. 1981 Jul; 71(1):38-46. PMID: 7246582.
      View in: PubMed
    417. Mohsenifar Z, Tashkin D, Levy SE, Bjerke RD, Clements PJ, Furst D. Lack of sensitivity of measurements of Vd/Vt at rest and during exercise in detection of hemodynamically significant pulmonary vascular abnormalities in collagen vascular disease. Am Rev Respir Dis. 1981 May; 123(5):508-12. PMID: 7235373.
      View in: PubMed
    418. Tashkin D, Calvarese BM, Simmons MS, Shapiro BJ. Respiratory status of seventy-four habitual marijuana smokers. Chest. 1980 Nov; 78(5):699-706. PMID: 7428453.
      View in: PubMed
    419. Deutsch RI, Tashkin D, Simmons M, Calvarese B, Wanger J, Lee YE. Bronchodilator effects of low doses of oral theophylline and terbutaline in asthmatic subjects. Ann Allergy. 1980 Sep; 45(3):137-43. PMID: 7416558.
      View in: PubMed
    420. Rokaw SN, Detels R, Coulson AH, Sayre JW, Tashkin D, Allwright SS, Massey FJ. The UCLA population studies of chronic obstructive respiratory disease. 3. Comparison of pulmonary function in three communities exposed to photochemical oxidants, multiple primary pollutants, or minimal pollutants. Chest. 1980 Aug; 78(2):252-62. PMID: 7398413.
      View in: PubMed
    421. Tashkin D, Trevor E, Chopra SK, Taplin GV. Sites of airway dilatation in asthma following inhaled versus subcutaneous terbutaline. Comparison of physiologic tests with radionuclide lung images. Am J Med. 1980 Jan; 68(1):14-26. PMID: 7350799.
      View in: PubMed
    422. Tashkin D, Detels R, Coulson AH, Rokaw SN, Sayre JW. The UCLA population studies of chronic obstructive respiratory disease. II. Determination of reliability and estimation of sensitivity and specificity. Environ Res. 1979 Dec; 20(2):403-24. PMID: 546647.
      View in: PubMed
    423. Ence TJ, Tashkin D, Ho D, Child JS. Acute bronchial and cardiovascular effects of oral pirbuterol and metaproterenol. Ann Allergy. 1979 Oct; 43(4):229-36. PMID: 555600.
      View in: PubMed
    424. Chopra SK, Taplin GV, Tashkin D, Trevor E, Elam D. Imaging sites of airway obstruction and measuring functional responses to bronchodilator treatment in asthma. Thorax. 1979 Aug; 34(4):493-500. PMID: 505346; PMCID: PMC471103.
    425. Bjerke RD, Tashkin D, Clements PJ, Chopra SK, Gong H, Bein M. Small airways in progressive systemic sclerosis (PSS). Am J Med. 1979 Feb; 66(2):201-9. PMID: 425965.
      View in: PubMed
    426. Chopra SK, Taplin GV, Tashkin D, Elam D. Lung clearance of soluble radioaerosols of different molecular weights in systemic sclerosis. Thorax. 1979 Feb; 34(1):63-7. PMID: 442001; PMCID: PMC471009.
    427. Detels R, Rokaw SN, Coulson AH, Tashkin D, Sayre JW, Massey FJ. The UCLA population studies of chronic obstructive respiratory disease. I. Methodology and comparison of lung function in areas of high and low pollution. Am J Epidemiol. 1979 Jan; 109(1):33-58. PMID: 433916.
      View in: PubMed
    428. Mohsenifar Z, Tashkin D. Effect of carboxyhemoglobin on the single breath diffusing capacity: derivation of an empirical correction factor. Respiration. 1979; 37(4):185-91. PMID: 472498.
      View in: PubMed
    429. Strumpf IJ, Simmons MS, Sayre JW, Tashkin D. Biorhythm theory and asthma. Ann Allergy. 1978 Dec; 41(6):330-2. PMID: 727569.
      View in: PubMed
    430. Rachelefsky GS, Tashkin D, Katz RM, Kershnar H, Siegel SC. Comparison of aerosolized atropine, isoproterenol, atropine plus isoproterenol, disodium cromoglycate and placebo in the prevention of exercise-induced asthma. Chest. 1978 Jun; 73(6 Suppl):1017-9. PMID: 98293.
      View in: PubMed
    431. Wolfe JD, Tashkin D, Calvarese B, Simmons M. Bronchodilator effects of terbutaline and aminophylline alone and in combination in asthmatic patients. N Engl J Med. 1978 Feb 16; 298(7):363-7. PMID: 340945.
      View in: PubMed
    432. Wolfe JD, Tashkin D, Holly FE, Brachman MB, Genovesi MG. Hypoxemia of cirrhosis: detection of abnormal small pulmonary vascular channels by a quantitative radionuclide method. Am J Med. 1977 Nov; 63(5):746-54. PMID: 930949.
      View in: PubMed
    433. Borut TC, Tashkin D, Fischer TJ, Katz R, Rachelefsky G, Siegel SC, Lee E, Harper C. Comparison of aerosolized atropine sulfate and SCH 1000 on exercise-induced bronchospasm in children. J Allergy Clin Immunol. 1977 Aug; 60(2):127-33. PMID: 141471.
      View in: PubMed
    434. Tashkin D, Levisman JA, Abbasi AS, Shapiro BJ, Ellis NM. Short-term effects of smoked marihuana on left ventricular function in man. Chest. 1977 Jul; 72(1):20-6. PMID: 326498.
      View in: PubMed
    435. Taplin GV, Tashkin D, Chopra SK, Anselmi OE, Elam D, Calvarese B, Coulson A, Detels R, Rokaw SN. Early detection of chronic obstructive pulmonary disease using radionuclide lung-imaging procedures. Chest. 1977 May; 71(5):567-75. PMID: 856554.
      View in: PubMed
    436. Genovesi MG, Tashkin D, Chopra S, Morgan M, McElroy C. Transient hypoxemia in firemen following inhalation of smoke. Chest. 1977 Apr; 71(4):441-4. PMID: 856542.
      View in: PubMed
    437. Tashkin D, Genovesi MG, Chopra S, Coulson A, Simmons M. Respiratory status of Los Angeles firemen. One-month follow-up after inhalation of dense smoke. Chest. 1977 Apr; 71(4):445-9. PMID: 852318.
      View in: PubMed
    438. Shapiro BJ, Tashkin D, Vachon L. Tetrahydrocannabinol as a bronchodilator. Why bother. Chest. 1977 Apr; 71(4):558-60. PMID: 852329.
      View in: PubMed
    439. Tashkin D, Reiss S, Shapiro BJ, Calvarese B, Olsen JL, Lodge JW. Bronchial effects of aerosolized delta 9-tetrahydrocannabinol in healthy and asthmatic subjects. Am Rev Respir Dis. 1977 Jan; 115(1):57-65. PMID: 319717.
      View in: PubMed
    440. Tashkin D, Shapiro BJ, Lee YE, Harper CE. Subacute effects of heavy marihuana smoking on pulmonary function in healthy men. N Engl J Med. 1976 Jan 15; 294(3):125-9. PMID: 1244507.
      View in: PubMed
    441. Olsen JL, Lodge JW, Shapiro BJ, Tashkin D. An inhalation aerosol of delta9-tetrahydrocannabinol. J Pharm Pharmacol. 1976 Jan; 28(1):86. PMID: 6665.
      View in: PubMed
    442. Tashkin D, Shapiro BJ, Lee YE, Harper CE. Effects of smoked marijuana in experimentally induced asthma. Am Rev Respir Dis. 1975 Sep; 112(3):377-86. PMID: 1099949.
      View in: PubMed
    443. Tashkin D, Meth R, Simmons DH, Lee YE. Double-blind comparison of acute bronchial and cardiovascular effects of oral terbutaline and ephedrine. Chest. 1975 Aug; 68(2):155-61. PMID: 1097203.
      View in: PubMed
    444. Child JS, Wolfe JD, Tashkin D, Nakano F. Fatal lung scan in a case of pulmonary hypertension due to obliterative pulmonary vascular disease. Chest. 1975 Mar; 67(3):308-10. PMID: 1112125.
      View in: PubMed
    445. Detels R, Coulson A, Tashkin D, Rokaw S. Reliability of plethysmography, the single breath oxygen test, and spirometry in population studies. Bull Physiopathol Respir (Nancy). 1975 Jan-Feb; 11(1):9-30. PMID: 1104017.
      View in: PubMed
    446. Nastro JA, Littner MR, Tashkin D, Cassan SM. Diffuse, pulmonary, interstitial infiltrate and mycoplasmal pneumonia. Am Rev Respir Dis. 1974 Nov; 110(5):659-62. PMID: 4429259.
      View in: PubMed
    447. Tashkin D, Shapiro BJ, Frank IM. Acute effects of smoked marijuana and oral delta9-tetrahydrocannabinol on specific airway conductance in asthmatic subjects. Am Rev Respir Dis. 1974 Apr; 109(4):420-8. PMID: 4816823.
      View in: PubMed
    448. Tashkin D, Shapiro BJ, Frank IM. Acute pulmonary physiologic effects of smoked marijuana and oral (Delta)9 -tetrahydrocannabinol in healthy young men. N Engl J Med. 1973 08 16; 289(7):336-41. PMID: 4718513.
      View in: PubMed